Metastasis Research

Cancer Center Support Grant (CCSG) Programs

500 Recent Publications

This is a list of the 20 publications most recently added to the Research Profiles database. This shows the publication activity that is ongoing at the institution.The source of publications for this application is Scopus.

  Select All    |   Export

• 1.

  2013

  Wael R. Abd-Elgaliel; Zobeida Cruz-Monserrate; Huamin Wang; Craig D. Logsdon; Ching-Hsuan Tung

  Pancreatic cancer-associated Cathepsin e as a drug activator

  Journal of Controlled Release. 2013;167(3):221-227.

• 2.

  2013

  Merrick I. Ross; Jeffrey E. Gershenwald

  Sentinel lymph node biopsy for melanoma: A critical update for dermatologists after two decades of experience

  Clinics in Dermatology. 2013;31(3):298-310.

• 3.

  2013

  Zhiqing Xing; Bryan S. Moon; Robert L. Satcher; Patrick P. Lin; Valerae O. Lewis

  A long femoral stem is not always required in hip arthroplasty for patients with proximal femur metastases tumor

  Clinical Orthopaedics and Related Research. 2013;471(5):1622-1627.

• 4.

  2013

  Anne S. Tsao; Suyu Liu; J. Jack Lee; Christine M. Alden; George R. Blumenschein Jr.; Roy Herbst; Suzanne E. Davis; Edward Kim; Scott Lippman; John Heymach; et al.

  Clinical and biomarker outcomes of the phase II vandetanib study from the BATTLE trial

  Journal of Thoracic Oncology. 2013;8(5):658-661.

• 5.

  2013

  Mian M.K. Shahzad; Yong-Hyun Shin; Koji Matsuo; Chunhua Lu; Masato Nishimura; De-Yo Shen; Yu Kang; Wei Hu; Edna M. Mora; Cristian Rodriguez-Aguayo; et al.

  Biological significance of HORMA domain containing protein 1 (HORMAD1) in epithelial ovarian carcinoma

  Cancer Letters. 2013;330(2):123-129.

• 6.

  2013

  Jaekyoung Son; Costas A. Lyssiotis; Haoqiang Ying; Xiaoxu Wang; Sujun Hua; Matteo Ligorio; Rushika M. Perera; Cristina R. Ferrone; Edouard Mullarky; Ng Shyh-Chang; et al.

  Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway

  Nature. 2013;496(7443):101-105.

• 7.

  2013

  Robert L. Coleman; Bradley J. Monk; Anil K. Sood; Thomas J. Herzog

  Latest research and treatment of advanced-stage epithelial ovarian cancer

  Nature Reviews Clinical Oncology. 2013;10(4):211-224.

• 8.

  2013

  Krithi Rao-Bindal; Chethan K. Rao; Ling Yu; Eugenie S. Kleinerman

  Expression of c-FLIP in pulmonary metastases in osteosarcoma patients and human xenografts

  Pediatric Blood and Cancer. 2013;60(4):575-579.

• 9.

  2013

  R.J. Schilder; M.W. Sill; H.A. Lankes; M.A. Gold; R.S. Mannel; S.C. Modesitt; P. Hanjani; A.J. Bonebrake; A.K. Sood; A.K. Godwin; et al.

  A phase II evaluation of motesanib (AMG 706) in the treatment of persistent or recurrent ovarian, fallopian tube and primary peritoneal carcinomas: A Gynecologic Oncology Group study

  Gynecologic Oncology. 2013;129(1):86-91.

• 10.

  2013

  Chantale Charo; Vijaykumar Holla; Thiruvengadam Arumugam; Rosa Hwang; Peiying Yang; Raymond N. Dubois; David G. Menter; Craig D. Logsdon; Vijaya Ramachandran

  Prostaglandin E₂ regulates pancreatic stellate cell activity via the EP4 receptor

  Pancreas. 2013;42(3):467-474.

• 11.

  2013

  Nitin K. Agarwal; Dubek Kazyken; Dos D. Sarbassov

  Rictor encounters RhoGDI2: The second pilot is taking a lead

  Small GTPases. 2013;4(2).

• 12.

  2013

  Farnaz C. Tahmasebi; Peter Farmer; Suzanne Z. Powell; Kenneth D. Aldape; Gregory N. Fuller; Shital Patel; Peter Hollis; David Chalif; Mark B. Eisenberg; Jian Yi Li

  Brain metastases from papillary thyroid carcinomas

  Virchows Archiv. 2013;462(4):473-480.

• 13.

  2013

  Isaiah Gregory Schauer; Jing Zhang; Zhen Xing; Xiaoqing Guo; Imelda Mercado-Uribe; Anil K. Sood; Peng Huang; Jinsong Liu

  Interleukin-1β promotes ovarian tumorigenesis through a p53/NF-κB-mediated inflammatory response in stromal fibroblasts

  Neoplasia (United States). 2013;15(4):409-420.

• 14.

  2013

  K. Kim; I. Jutooru; G. Chadalapaka; G. Johnson; J. Frank; R. Burghardt; S. Kim; S. Safe

  HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer

  Oncogene. 2013;32(13):1616-1625.

• 15.

  2013

  Min Chen; Paolo Gallipoli; Donna Degeer; Ivan Sloma; Donna L. Forrest; Matthew Chan; Damian Lai; Heather Jorgensen; Ashley Ringrose; Hui Mi Wang; et al.

  Targeting primitive chronic myeloid leukemia cells by effective inhibition of a new AHI-1-BCR-ABL-JAK2 complex

  Journal of the National Cancer Institute. 2013;105(6):405-423.

• 16.

  2013

  Craig D. Logsdon; Baoan Ji

  The role of protein synthesis and digestive enzymes in acinar cell injury

  Nature Reviews Gastroenterology and Hepatology. 2013.

• 17.

  2013

  Brett G. Hollier; Agata A. Tinnirello; Steven J. Werden; Kurt W. Evans; Joseph H. Taube; Tapasree Roy Sarkar; Nathalie Sphyris; Maryam Shariati; Sreedevi V. Kumar; Venkata L. Battula; et al.

  FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancer

  Cancer Research. 2013;73(6):1981-1992.

• 18.

  2013

  Guillermo N. Armaiz-Pena; Steve W. Cole; Susan K. Lutgendorf; Anil K. Sood

  Neuroendocrine influences on cancer progression

  Brain, Behavior, and Immunity. 2013;30(SUPPL.):S19-S25.

• 19.

  2013

  Andrew Schrepf; Lauren Clevenger; Desire Christensen; Koen DeGeest; David Bender; Amina Ahmed; Michael J. Goodheart; Laila Dahmoush; Frank Penedo; Joseph A. Lucci; et al.

  Cortisol and inflammatory processes in ovarian cancer patients following primary treatment: Relationships with depression, fatigue, and disability

  Brain, Behavior, and Immunity. 2013;30(SUPPL.):S126-S134.

• 20.

  2013

  Huijuan Song; Suet-Yan Kwan; Daisy I. Izaguirre; Zhifei Zu; Yvonne T. Tsang; Celestine S. Tung; Erin R. King; Samuel C. Mok; David M. Gershenson; Kwong-Kwok Wong

  PAX2 expression in ovarian cancer

  International Journal of Molecular Sciences. 2013;14(3):6090-6105.

• 21.

  2013

  James W. Welsh; Ritsuko Komaki; Arya Amini; Mark F. Munsell; Wyatt Unger; Pamela K. Allen; Joe Y. Chang; Jeffrey S. Wefel; Susan L. McGovern; Linda L. Garland; et al.

  Phase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancer

  Journal of Clinical Oncology. 2013;31(7):895-902.

• 22.

  2013

  D.G. Thomas; M.M. Tabb; J.M. Larios; D.P. Hughes; T.J. Giordano; M.L. Lizyness; J.M. Rae; B. Blumberg; P.F. Hollenberg; L.H. Baker

  Erratum: Expression levels and activation of a PXR variant are directly related to drug resistance in osteosarcoma cell lines (Cancer (2007) 109 (957-965))

  Cancer. 2013;119(5):1115.

• 23.

  2013

  Wesley O. Greaves; Shalini Verma; Keyur P. Patel; Michael A. Davies; Bedia A. Barkoh; John M. Galbincea; Hui Yao; Alexander J. Lazar; Kenneth D. Aldape; L. Jeffrey Medeiros; et al.

  Frequency and spectrum of BRAF mutations in a retrospective, single-institution study of 1112 cases of melanoma

  Journal of Molecular Diagnostics. 2013;15(2):220-226.

• 24.

  2013

  Cristina Ivan; Wei Hu; Justin Bottsford-Miller; Behrouz Zand; Heather J. Dalton; Tao Liu; Jie Huang; Alpa M. Nick; Gabriel Lopez-Berestein; Robert L. Coleman; et al.

  Epigenetic analysis of the Notch superfamily in high-grade serous ovarian cancer

  Gynecologic Oncology. 2013;128(3):506-511.

• 25.

  2013

  Fernanda T. Borges; Sonia A. Melo; Berna C. Özdemir; Noritoshi Kato; Ignacio Revuelta; Caroline A. Miller; Vincent H. Gattone II; Valerie S. LeBleu; Raghu Kalluri

  TGF-β1-Containing exosomes from injured epithelial cells activate fibroblasts to initiate tissue regenerative responses and fibrosis

  Journal of the American Society of Nephrology. 2013;24(3):385-392.

• 26.

  2013

  Tiewei Cheng; Beat Roth; Woonyoung Choi; Peter C. Black; Colin Dinney; David J. McConkey

  Fibroblast Growth Factor Receptors-1 and -3 Play Distinct Roles in the Regulation of Bladder Cancer Growth and Metastasis: Implications for Therapeutic Targeting

  PLoS ONE. 2013;8(2).

• 27.

  2013

  Sandra H E Boots-Sprenger; Angelique Sijben; Jos Rijntjes; Bastiaan B J Tops; Albert J Idema; Andreana L Rivera; Fonnet E Bleeker; Anja M Gijtenbeek; Kristin Diefes; Lindsey Heathcock; et al.

  Significance of complete 1p/19q co-deletion, IDH1 mutation and MGMT promoter methylation in gliomas: use with caution

  Modern Pathology. 2013.

• 28.

  2013

  Hasse Brønnum; Ditte C. Andersen; Mikael Schneider; Maria B. Sandberg; Tilde Eskildsen; Solveig B. Nielsen; Raghu Kalluri; Søren P. Sheikh

  miR-21 Promotes Fibrogenic Epithelial-to-Mesenchymal Transition of Epicardial Mesothelial Cells Involving Programmed Cell Death 4 and Sprouty-1

  PLoS ONE. 2013;8(2).

• 29.

  2013

  Steve B. Reyes; Anjana S. Narayanan; Hye Shin Lee; Jeremy H. Tchaicha; Kenneth D. Aldape; Frederick F. Lang; Kimberly F. Tolias; Joseph H. McCarty

  αvβ8 integrin interacts with RhoGDI1 to regulate Rac1 and Cdc42 activation and drive glioblastoma cell invasion

  Molecular Biology of the Cell. 2013;24(4):474-482.

• 30.

  2013

  Tarrik M. Zaid; Tsz-Lun Yeung; Melissa S. Thompson; Cecilia S. Leung; Tom Harding; Ngai-Na Co; Rosie S. Schmandt; Suet-Ying Kwan; Cristian Rodriguez-Aguay; Gabriel Lopez-Berestein; et al.

  Identification of FGFR4 as a potential therapeutic target for advanced-stage, high-grade serous ovarian cancer

  Clinical Cancer Research. 2013;19(4):809-820.

• 31.

  2013

  Peter E. Zage; Natalie Sirisaengtaksin; Yin Liu; Monica Gireud; Brandon S. Brown; Shana Palla; Kristen N. Richards; Dennis P. M. Hughes; Andrew J. Bean

  UBE4B levels are correlated with clinical outcomes in neuroblastoma patients and with altered neuroblastoma cell proliferation and sensitivity to epidermal growth factor receptor inhibitors

  Cancer. 2013;119(4):915-923.

• 32.

  2013

  Chunying Li; Ming Yin; Li-E Wang; Christopher I Amos; Dakai Zhu; Jeffrey E Lee; Jeffrey E Gershenwald; Elizabeth A Grimm; Qingyi Wei

  Polymorphisms of Nucleotide Excision Repair Genes Predict Melanoma Survival

  Journal of Investigative Dermatology. 2013.

• 33.

  2013

  Jia Lu; Xiangcang Ye; Fan Fan; Ling Xia; Rajat Bhattacharya; Seth Bellister; Federico Tozzi; Eric Sceusi; Yunfei Zhou; Isamu Tachibana; et al.

  Endothelial Cells Promote the Colorectal Cancer Stem Cell Phenotype through a Soluble Form of Jagged-1

  Cancer Cell. 2013;23(2):171-185.

• 34.

  2013

  Da Yang; Yan Sun; Limei Hu; Hong Zheng; Ping Ji; Chad V. Pecot; Yanrui Zhao; Sheila Reynolds; Hanyin Cheng; Rajesha Rupaimoole; et al.

  Integrated Analyses Identify a Master MicroRNA Regulatory Network for the Mesenchymal Subtype in Serous Ovarian Cancer

  Cancer Cell. 2013;23(2):186-199.

• 35.

  2013

  Carlos A. Melo; Jarno Drost; Patrick J. Wijchers; Harmen van de Werken; Elzo de Wit; Joachim A.F. Oude Vrielink; Ran Elkon; Sónia A. Melo; Nicolas Léveillé; Raghu Kalluri; et al.

  ERNAs Are Required for p53-Dependent Enhancer Activity and Gene Transcription

  Molecular Cell. 2013;49(3):524-535.

• 36.

  2013

  Sankaranarayanan Kannan; Robert M. Sutphin; Mandy G. Hall; Leonard S. Golfman; Wendy Fang; Riitta M. Nolo; Lauren J. Akers; Richard A. Hammitt; John S. McMurray; Steven M. Kornblau; et al.

  Notch activation inhibits AML growth and survival: A potential therapeutic approach

  Journal of Experimental Medicine. 2013;210(2):321-337.

• 37.

  2013

  Valerie S. Lebleu; Yingqi Teng; Joyce T. O'Connell; David Charytan; Gerhard A. Müller; Claudia A. Müller; Hikaru Sugimoto; Raghu Kalluri

  Identification of human epididymis protein-4 as a fibroblast-derived mediator of fibrosis

  Nature Medicine. 2013;19(2):227-231.

• 38.

  2013

  John Farley; William E Brady; Vinod Vathipadiekal; Heather A Lankes; Robert Coleman; Mark A Morgan; Robert Mannel; S Diane Yamada; David Mutch; William H Rodgers; et al.

  Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: An open-label, Single-arm, Phase 2 study

  The Lancet Oncology. 2013;14(2):134-140.

• 39.

  2013

  William N. William; Apar Pataer; Neda Kalhor; Arlene M. Correa; David C. Rice; Ignacio I. Wistuba; John Heymach; J. Jack Lee; Edward S. Kim; Reginald Munden; et al.

  Computed tomography recist assessment of histopathologic response and prediction of survival in patients with resectable non-small-cell lung cancer after neoadjuvant chemotherapy

  Journal of Thoracic Oncology. 2013;8(2):222-228.

• 40.

  2013

  Mai N. Tran; Woonyoung Choi; Matthew F. Wszolek; Neema Navai; I-Ling C. Lee; Giovanni Nitti; Sijin Wen; Elsa R. Flores; Arlene Siefker-Radtke; Bogdan Czerniak; et al.

  The p63 protein isoform ΔNp63α inhibits epithelial-mesenchymal transition in human bladder cancer cells: Role of miR-205

  Journal of Biological Chemistry. 2013;288(5):3275-3288.

• 41.

  2013

  Michael Zeisberg; Raghu Kalluri

  Cellular mechanisms of tissue fibrosis. 1. Common and organ-specific mechanisms associated with tissue fibrosis

  American Journal of Physiology - Cell Physiology. 2013;304(3):C216-C225.

• 42.

  2013

  Archana S. Nagaraja; Guillermo N. Armaiz-Pena; Susan K. Lutgendorf; Anil K. Sood

  Why stress is BAD for cancer patients

  Journal of Clinical Investigation. 2013;123(2):558-560.

• 43.

  2013

  Sonia A. Melo; Raghu Kalluri

  MiR-29b moulds the tumour microenvironment to repress metastasis

  Nature Cell Biology. 2013;15(2):139-140.

• 44.

  2013

  Justyna Kopycinska; Agnieszka Kempińska-Podhorodecka; Tara Haas; Elwyn Elias; Ronald A. Depinho; Jihye Paik; Piotr Milkiewicz; Malgorzata Milkiewicz

  Activation of FoxO3a/Bim axis in patients with Primary Biliary Cirrhosis

  Liver International. 2013;33(2):231-238.

• 45.

  2013

  Takahito M. Miyake; Anil K. Sood; Robert L. Coleman

  Contemporary use of bevacizumab in ovarian cancer

  Expert Opinion on Biological Therapy. 2013;13(2):283-294.

• 46.

  2013

  Y-C Chen; J Y-H Chan; Y-L Chiu; S-T Liu; G Lozano; S-L Wang; C-L Ho; S-M Huang

  Grail as a molecular determinant for the functions of the tumor suppressor p53 in tumorigenesis

  Cell Death and Differentiation. 2013.

• 47.

  2013

  Jun Zhou; Ju-Won Roh; Sudeshna Bandyopadhyay; Zhengming Chen; Adnan R. Munkarah; Yaser Hussein; Baraa Alosh; Tarek Jazaerly; Kinda Hayek; Assaad Semaan; et al.

  Overexpression of enhancer of zeste homolog 2 (EZH2) and focal adhesion kinase (FAK) in high grade endometrial carcinoma

  Gynecologic Oncology. 2013;128(2):344-348.

• 48.

  2013

  Xiaohua Su; Deepavali Chakravarti; Elsa R. Flores

  P63 steps into the limelight: Crucial roles in the suppression of tumorigenesis and metastasis

  Nature Reviews Cancer. 2013;13(2):136-143.

• 49.

  2013

  Khatri Latha; Ming Li; Vaibhav Chumbalkar; Anupama Gururaj; Yeohyeon Hwang; Sumana Dakeng; Raymond Sawaya; Kenneth Aldape; Webster K. Cavenee; Oliver Bogler; et al.

  Nuclear EGFRvIII-STAT5b complex contributes to glioblastoma cell survival by direct activation of the Bcl-XL promoter

  International Journal of Cancer. 2013;132(3):509-520.

• 50.

  2013

  Jeffry Cutrera; Blake Johnson; Lee Ellis; Shulin Li

  Intraosseous inoculation of tumor cells into bone marrow promotes distant metastatic tumor development: A novel tool for mechanistic and therapeutic studies

  Cancer Letters. 2013;329(1):68-73.

• 51.

  2013

  H Huang; J Daniluk; Y Liu; J Chu; Z Li; B Ji; C D Logsdon

  Oncogenic K-Ras requires activation for enhanced activity

  Oncogene. 2013.

• 52.

  2013

  Bingbing Dai; Aihua Gong; Zhitao Jing; Kenneth D. Aldape; Shin-Hyuk Kang; Raymond Sawaya; Suyun Huang

  Forkhead Box M1 is regulated by heat shock factor 1 and promotes glioma cells survival under heat shock stress

  Journal of Biological Chemistry. 2013;288(3):1634-1642.

• 53.

  2013

  Pierre Saintigny; Erminia Massarelli; Steven Lin; Young-Ho Ahn; Yulong Chen; Sangeeta Goswami; Baruch Erez; Michael S. O'Reilly; Diane Liu; J. Jack Lee; et al.

  CXCR2 expression in tumor cells is a poor prognostic factor and promotes invasion and metastasis in lung adenocarcinoma

  Cancer Research. 2013;73(2):571-582.

• 54.

  2013

  Yixin Yao; Milind Suraokar; Bryant G. Darnay; Brett G. Hollier; Tattym E. Shaiken; Takayuki Asano; Chien-Hung Chen; Benny H.-J. Chang; Yiling Lu; Gordon B. Mills; et al.

  BSTA promotes mTORC2-mediated phosphorylation of Akt1 to suppress expression of FoxC2 and stimulate adipocyte differentiation

  Science Signaling. 2013;6(257).

• 55.

  2013

  Francesco Niola; Xudong Zhao; Devendra Singh; Ryan Sullivan; Angelica Castano; Antonio Verrico; Pietro Zoppoli; Dinorah Friedmann-Morvinski; Erik Sulman; Lindy Barrett; et al.

  Mesenchymal high-grade glioma is maintained by the ID-RAP1 axis

  Journal of Clinical Investigation. 2013;123(1):405-417.

• 56.

  2013

  Shannon J. Gallagher; Amber E. Kofman; Jessica M. Huszar; Jan-Hermen Dannenberg; Ronald A. DePinho; Robert E. Braun; Christopher J. Payne

  Distinct requirements for Sin3a in perinatal male gonocytes and differentiating spermatogonia

  Developmental Biology. 2013;373(1):83-94.

• 57.

  2013

  Dennis P.M. Hughes; Dafydd G. Thomas; Thomas J. Giordano; Kevin T. Mcdonagh; Laurence H. Baker

  Erratum: Essential erbB family phosphorylation in osteosarcoma as a target for CI-1033 inhibition

  Pediatric Blood and Cancer. 2013;60(1):169-169.

• 58.

  2013

  Yuqing Zhang; Leon Chen; Jingxuan Yang; Jason B. Fleming; Paul J. Chiao; Craig D. Logsdon; Min Li

  Study human pancreatic cancer in mice: How close are they?

  Biochimica et Biophysica Acta - Reviews on Cancer. 2013;1835(1):110-118.

• 59.

  2013

  Haojie Huang; Yan Liu; Jaroslaw Daniluk; Sebastian Gaiser; Jun Chu; Huamin Wang; Zhao-Shen Li; Craig D. Logsdon; Baoan Ji

  Activation of nuclear factor-κB in acinar cells increases the severity of pancreatitis in mice

  Gastroenterology. 2013;144(1):202-210.

• 60.

  2013

  Weiwei Yang; Yanhua Zheng; Yan Xia; Haitao Ji; Xiaomin Chen; Fang Guo; Costas A. Lyssiotis; Kenneth Aldape; Lewis C. Cantley; Zhimin Lu

  Erratum: ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect (Nature Cell Biology (2012) 14 (1295-1304))

  Nature Cell Biology. 2013;15(1):124.

• 61.

  2013

  Eleni Efstathiou; Maria Karlou; Sijin Wen; Anh Hoang; Curtis A. Pettaway; Louis L. Pisters; Sankar Maity; Patricia Troncoso; Christopher J. Logothetis

  Integrated Hedgehog signaling is induced following castration in human and murine prostate cancers

  Prostate. 2013;73(2):153-161.

• 62.

  2013

  Bruce J. Roth; Lada Krilov; Sylvia Adams; Carol A. Aghajanian; Peter Bach; Fadi Braiteh; Marcia S. Brose; Lee M. Ellis; Harry Erba; Daniel J. George; et al.

  Clinical cancer advances 2012: Annual report on progress against cancer from the American Society of Clinical Oncology

  Journal of Clinical Oncology. 2013;31(1):131-161.

• 63.

  2013

  Angela J. Ziebarth; Somaira Nowsheen; Adam D. Steg; Monjri M. Shah; Ashwini A. Katre; Zachary C. Dobbin; Hee-Dong Han; Gabriel Lopez-Berestein; Anil K. Sood; Michael Conner; et al.

  Endoglin (CD105) contributes to platinum resistance and is a target for tumor-specific therapy in epithelial ovarian cancer

  Clinical Cancer Research. 2013;19(1):170-182.

• 64.

  2013

  Xiaoxiang Guan; Jiangong Niu; Zhensheng Liu; Li-E. Wang; Christopher I. Amos; Jeffrey E. Lee; Jeffrey E. Gershenwald; Elizabeth A. Grimm; Qingyi Wei

  Variants in melanocortin 1 receptor gene contribute to risk of melanoma - a direct sequencing analysis in a Texas population

  Pigment Cell and Melanoma Research. 2013.

• 65.

  2013

  Vikas Bhardwaj; Tina Cascone; Maria Angelica Cortez; Arya Amini; Jaden Evans; Ritsuko U. Komaki; John V. Heymach; James W. Welsh

  Modulation of c-Met signaling and cellular sensitivity to radiation: Potential implications for therapy

  Cancer. 2013.

• 66.

  2013

  Christoph Kahlert; Raghu Kalluri

  Exosomes in tumor microenvironment influence cancer progression and metastasis

  Journal of Molecular Medicine. 2013:1-7.

• 67.

  2013

  Jeffrey T. Chang; Sendurai A. Mani

  Sheep, wolf, or werewolf: Cancer stem cells and the epithelial-to-mesenchymal transition

  Cancer Letters. 2013.

• 68.

  2013

  Aditya Raghunathan; Khalida Wani; Terri S. Armstrong; Elizabeth Vera-Bolanos; Maryam Fouladi; Richard Gilbertson; Amar Gajjar; Stewart Goldman; Norman L. Lehman; Phillipe Metellus; et al.

  Histological Predictors of Outcome in Ependymoma are Dependent on Anatomic Site Within the Central Nervous System

  Brain Pathology. 2013.

• 69.

  2013

  Surena F. Matin; Janice N. Cormier; John F. Ward; Louis L. Pisters; Christopher G. Wood; Colin P.N. Dinney; Richard E. Royal; Xuelin Huang; Curtis A. Pettaway

  Phase 1 prospective evaluation of the oncological adequacy of robotic assisted video-endoscopic inguinal lymphadenectomy in patients with penile carcinoma

  BJU International. 2013.

• 70.

  2013

  Nadezhda V. Koshkina; Ge Yang; Eugenie S. Kleinerman

  Inhibition of Cdc42-interacting protein 4 (CIP4) impairs osteosarcoma tumor progression

  Current Cancer Drug Targets. 2013;13(1):48-56.

• 71.

  2013

  David F.B. Miller; Pearlly S. Yan; Aaron Buechlein; Benjamin A. Rodriguez; Ayse S. Yilmaz; Shokhi Goel; Hai Lin; Bridgette Collins-Burow; Lyndsay V. Rhodes; Chris Braun; et al.

  A new method for stranded whole transcriptome RNA-seq

  Methods. 2013.

• 72.

  2013

  Robert L. Coleman; Michael W. Sill; Heather A. Lankes; Amanda Nickles Fader; Neil J. Finkler; James S. Hoffman; Peter G. Rose; Gregory P. Sutton; Charles W. Drescher; D. Scott McMeekin; et al.

  Corrigendum to "A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: A Gynecologic Oncology Group study" [Gynecol Oncol 127 (2012) 538-543] (DOI:10.1016/j.ygyno.2012.08.020)

  Gynecologic Oncology. 2013.

• 73.

  2013

  Takafumi Kamiya; Aaron K. Mobley; Menashe Bar-Eli

  Crossing the junction in the gap of melanoma brain metastasis

  Pigment Cell and Melanoma Research. 2013.

• 74.

  2013

  Martin J. van den Bent; C. Hartmann; Matthias Preusser; Thomas Ströbel; Hendrikus J. Dubbink; Johan M. Kros; Andreas von Deimling; Blandine Boisselier; Marc Sanson; Kevin C. Halling; et al.

  Interlaboratory comparison of IDH mutation detection

  Journal of Neuro-Oncology. 2013:1-6.

• 75.

  2013

  Karen Gambaro; Michael C.J. Quinn; Paulina M. Wojnarowicz; Suzanna L. Arcand; Manon de Ladurantaye; Véronique Barrès; Jean-Sébastien Ripeau; Ann M. Killary; Elaine C. Davis; Josée Lavoie; et al.

  VGLL3 expression is associated with a tumor suppressor phenotype in epithelial ovarian cancer

  Molecular Oncology. 2013.

• 76.

  2013

  Gong Yang; Imelda Mercado-Uribe; Asha S. Multani; Subrata Sen; Ie-Ming Shih; Kwong-Kwok Wong; David M. Gershenson; Jinsong Liu

  RAS promotes tumorigenesis through genomic instability induced by imbalanced expression of Aurora-A and BRCA2 in midbody during cytokinesis

  International Journal of Cancer. 2013.

• 77.

  2013

  Lawrence A. Donehower; Chad J. Creighton; Nikolaus Schultz; Eve Shinbrot; Kyle Chang; Preethi H. Gunaratne; Donna Muzny; Chris Sander; Stanley R. Hamilton; Richard A. Gibbs; et al.

  MLH1 -silenced and non-silenced subgroups of hypermutated colorectal carcinomas have distinct mutational landscapes

  Journal of Pathology. 2013;229(1):99-110.

• 78.

  2013

  Nicole Shonka; Yuji Piao; Mark Gilbert; Alfred Yung; Susan Chang; Lisa M. DeAngelis; Andrew B. Lassman; Jun Liu; Timothy Cloughesy; H.Ian Robins; et al.

  Cytokines associated with toxicity in the treatment of recurrent glioblastoma with aflibercept

  Targeted Oncology. 2013:1-9.

• 79.

  2013

  Qin Li; Guillermina Lozano

  Molecular pathways: Targeting Mdm2 and Mdm4 in cancer therapy

  Clinical Cancer Research. 2013;19(1):34-41.

• 80.

  2013

  Lauren Averett Byers; Lixia Diao; Jing Wang; Pierre Saintigny; Luc Girard; Michael Peyton; Li Shen; Youhong Fan; Uma Giri; Praveen K. Tumula; et al.

  An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance

  Clinical Cancer Research. 2013;19(1):279-290.

• 81.

  2012

  Valerie Cortez; Monica Mann; Seshidhar Tekmal; Takayoshi Suzuki; Naoki Miyata; Cristian Rodriguez-Aguayo; Gabriel Lopez-Berestein; Anil K. Sood; Ratna K. Vadlamudi

  Correction: Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer

  Breast Cancer Research. 2012;14(6).

• 82.

  2012

  Vinod Pant; Alfonso Quintás-Cardama; Guillermina Lozano

  The p53 pathway in hematopoiesis: Lessons from mouse models, implications for humans

  Blood. 2012;120(26):5118-5127.

• 83.

  2012

  Sangkyou Lee; Ilkyun Lee; Yoonsuh Jung; David McConkey; Bogdan Czerniak

  In-Frame cDNA Library Combined with Protein Complementation Assay Identifies ARL11-Binding Partners

  PLoS ONE. 2012;7(12).

• 84.

  2012

  Longjiang Shao; Ibrahim Tekedereli; Jianghua Wang; Erkan Yuca; Susan Tsang; Anil Sood; Gabriel Lopez-Berestein; Bulent Ozpolat; Michael Ittmann

  Highly specific targeting of the TMPRSS2/ERG fusion gene using liposomal nanovectors

  Clinical Cancer Research. 2012;18(24):6648-6657.

• 85.

  2012

  Laszlo G. Radvanyi; Chantale Bernatchez; Minying Zhang; Patricia S. Fox; Priscilla Miller; Jessica Chacon; Richard Wu; Gregory Lizee; Sandy Mahoney; Gladys Alvarado; et al.

  Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients

  Clinical Cancer Research. 2012;18(24):6758-6770.

• 86.

  2012

  Moubin Lin; Cathy Eng; Ernest T. Hawk; Maosheng Huang; Jie Lin; Jian Gu; Lee M. Ellis; Xifeng Wu

  Identification of polymorphisms in ultraconserved elements associated with clinical outcomes in locally advanced colorectal adenocarcinoma

  Cancer. 2012;118(24):6188-6198.

• 87.

  2012

  Weiwei Yang; Yan Xia; Yu Cao; Yanhua Zheng; Wen Bu; Lin Zhang; M. James You; Mei Yee Koh; Gilbert Cote; Kenneth Aldape; et al.

  EGFR-Induced and PKCε Monoubiquitylation-Dependent NF-κB Activation Upregulates PKM2 Expression and Promotes Tumorigenesis

  Molecular Cell. 2012;48(5):771-784.

• 88.

  2012

  Min Soon Cho; Justin Bottsford-Miller; Hernan G. Vasquez; Rebecca Stone; Behrouz Zand; Michael H. Kroll; Anil K. Sood; Vahid Afshar-Kharghan

  Platelets increase the proliferation of ovarian cancer cells

  Blood. 2012;120(24):4869-4872.

• 89.

  2012

  Robert L. Coleman; Michael W. Sill; Heather A. Lankes; Amanda Nickles Fader; Neil J. Finkler; James S. Hoffman; Peter G. Rose; Gregory P. Sutton; Charles W. Drescher; D. Scott McMeekin; et al.

  A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: A Gynecologic Oncology Group study

  Gynecologic Oncology. 2012;127(3):538-543.

• 90.

  2012

  Aaron K. Mobley; Russell R. Braeuer; Takafumi Kamiya; Einav Shoshan; Menashe Bar-Eli

  Driving transcriptional regulators in melanoma metastasis

  Cancer and Metastasis Reviews. 2012;31(3-4):621-632.

• 91.

  2012

  Sasidharan Smitha; Vadakkenchery S. Haseena; Tharangattu N. Narayanan; Antony P. Reena Mary; Pulickel M. Ajayan; Jayesh Puthumana; Anas A. Aziz; Rebeca R. Aburto; Sendurai A. Mani; Pattayil A. Joy; et al.

  Fluorescent superparamagnetic iron oxide core-shell nanoprobes for multimodal cellular imaging

  Materials Express. 2012;2(4):265-274.

• 92.

  2012

  Adriana Olar; Kenneth D. Aldape

  Biomarkers classification and therapeutic decision-making for malignant gliomas

  Current Treatment Options in Oncology. 2012;13(4):417-436.

• 93.

  2012

  Weiwei Yang; Yanhua Zheng; Yan Xia; Haitao Ji; Xiaomin Chen; Fang Guo; Costas A. Lyssiotis; Kenneth Aldape; Lewis C. Cantley; Zhimin Lu

  ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect

  Nature Cell Biology. 2012;14(12):1295-1304.

• 94.

  2012

  Eudocia Q. Lee; John Kuhn; Kathleen R. Lamborn; Lauren Abrey; Lisa M. Deangelis; Frank Lieberman; H. Ian Robins; Susan M. Chang; W.K. Alfred Yung; Jan Drappatz; et al.

  Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02

  Neuro-Oncology. 2012;14(12):1511-1518.

• 95.

  2012

  Gaurav Aggarwal; Vijaya Ramachandran; Naureen Javeed; Thiruvengadam Arumugam; Shamit Dutta; George G. Klee; Eric W. Klee; Thomas C. Smyrk; William Bamlet; Jing Jing Han; et al.

  Adrenomedullin is up-regulated in patients with pancreatic cancer and causes insulin resistance in β cells and mice

  Gastroenterology. 2012;143(6):1510-1517.e1.

• 96.

  2012

  Patricia Thompson; Denise J. Roe; Liane Fales; Julie Buckmeier; Fang Wang; Stanley R. Hamilton; Achyut Bhattacharyya; Sylvan Green; Chiu-Hsieh Hsu; H.-H. Sherry Chow; et al.

  Design and baseline characteristics of participants in a phase III randomized trial of celecoxib and selenium for colorectal adenoma prevention

  Cancer Prevention Research. 2012;5(12):1381-1393.

• 97.

  2012

  Patrick A. Zweidler-McKay

  Clone wars: IgH subclones in preB-ALL

  Blood. 2012;120(22):4280-4281.

• 98.

  2012

  Xiaozhong Shi; Alicia M. Wallis; Robert D. Gerard; Kevin A. Voelker; Robert W. Grange; Ronald A. DePinho; Mary G. Garry; Daniel J. Garry

  Foxk1 promotes cell proliferation and represses myogenic differentiation by regulating Foxo4 and Mef2

  Journal of Cell Science. 2012;125(22):5329-5337.

• 99.

  2012

  Russell R. Braeuer; Maya Zigler; Takafumi Kamiya; Andrey S. Dobroff; Li Huang; Woonyoung Choi; David J. McConkey; Einav Shoshan; Aaron K. Mobley; Renduo Song; et al.

  Galectin-3 contributes to melanoma growth and metastasis via regulation of NFAT1 and autotaxin

  Cancer Research. 2012;72(22):5757-5766.

• 100.

  2012

  Justin N. Bottsford-Miller; Robert L. Coleman; Anil K. Sood

  Resistance and escape from antiangiogenesis therapy: Clinical implications and future strategies

  Journal of Clinical Oncology. 2012;30(32):4026-4034.

• 101.

  2012

  Chia-Hsin Chan; Chien-Feng Li; Wei-Lei Yang; Yuan Gao; Szu-Wei Lee; Zizhen Feng; Hsuan-Ying Huang; Kelvin K.C. Tsai; Leo G. Flores; Yiping Shao; et al.

  Erratum: The Skp2-SCF E3 ligase regulates akt ubiquitination, glycolysis, herceptin sensitivity, and tumorigenesis (Cell (2012) 149 (1098-1111))

  Cell. 2012;151(4):913-914.

• 102.

  2012

  Xiwen Xiong; Rongya Tao; Ronald A. DePinho; X. Charlie Dong

  The autophagy-related gene 14 (Atg14) is regulated by forkhead box O transcription factors and circadian rhythms and plays a critical role in hepatic autophagy and lipid metabolism

  Journal of Biological Chemistry. 2012;287(46):39107-39114.

• 103.

  2012

  Justin E. Bird; Wei-Lien Wang; Michael T. Deavers; John Madewell; Valerae O. Lewis

  Enchondroma with secondary aneurysmal bone cyst

  Skeletal Radiology. 2012;41(11):1475-1478.

• 104.

  2012

  Vivian Colón-López; Ana P. Ortiz; Marievelisse Soto-Salgado; Mariela Torres-Cintrón; Curtis A. Pettaway; Antonio Puras-Báez; Magaly Martínez-Ferrer; Erick Suárez

  Penile Cancer Disparities in Puerto Rican Men as compared to the United States Population

  International Braz J Urol. 2012;38(6):728-737.

• 105.

  2012

  Robert J. Morgan Jr.; Ronald D. Alvarez; Deborah K. Armstrong; Robert A. Burger; Mariana Castells; Lee-May Chen; Larry Copeland; Marta Ann Crispens; David Gershenson; Heidi Gray; et al.

  Ovarian cancer, version 3.2012: Featured updates to the NCCN guidelines

  JNCCN Journal of the National Comprehensive Cancer Network. 2012;10(11):1339-1349.

• 106.

  2012

  P. Zhang; Y. Yang; R. Nolo; P.A. Zweidler-Mckay; D.P.M. Hughes

  Erratum: Regulation of NOTCH signaling by reciprocal inhibition of HES1 and Deltex 1 and its role in osteosarcoma invasiveness (Oncogene (2010) 29 (2916-2926) DOI: 10.1038/onc.2010.62)

  Oncogene. 2012;31(44):47332.

• 107.

  2012

  Curtis A. Pettaway; Juanita Crook; Paul K. Hegarty; Lance Pagliaro

  Penile cancer update 2011: A case-based approach

  Urologic Oncology: Seminars and Original Investigations. 2012;30(6):956-958.

• 108.

  2012

  Antonio Giordano; Hui Gao; Simone Anfossi; Evan Cohen; Michal Mego; Bang-Ning Lee; Sanda Tin; Michele De Laurentiis; Charla A. Parker; Ricardo H. Alvarez; et al.

  Epithelial-mesenchymal transition and stem cell markers in patients with HER2-positive metastatic breast cancer

  Molecular Cancer Therapeutics. 2012;11(11):2526-2534.

• 109.

  2012

  Yuji Piao; Ji Liang; Lindsay Holmes; Amado J. Zurita; Verlene Henry; John V. Heymach; John F. De Groot

  Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype

  Neuro-Oncology. 2012;14(11):1379-1392.

• 110.

  2012

  Rian J. Dickstein; Giovanni Nitti; Colin P. Dinney; Barry R. Davies; Ashish M. Kamat; David J. McConkey

  Autophagy limits the cytotoxic effects of the AKT inhibitor AZ7328 in human bladder cancer cells

  Cancer Biology and Therapy. 2012;13(13):1325-1338.

• 111.

  2012

  G.J. Villares; M. Zigler; K. Blehm; C. Bogdan; D. McConkey; D. Colin; Menashe Bar-Eli

  Erratum to: Retraction Note: Targeting EGFR in bladder cancer (World J Urol, (2007), 25, (573-579), 10.1007/s00345-007-0202-7)

  World Journal of Urology. 2012;30(5):723.

• 112.

  2012

  James G. Jackson; Guillermina Lozano

  Che-ating death: CHE1/AATF protects from p53-mediated apoptosis

  EMBO Journal. 2012;31(20):3951-3953.

• 113.

  2012

  Dominik Sturm; Hendrik Witt; Volker Hovestadt; Dong-Anh Khuong-Quang; David T.W. Jones; Carolin Konermann; Elke Pfaff; Martje Tönjes; Martin Sill; Sebastian Bender; et al.

  Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma

  Cancer Cell. 2012;22(4):425-437.

• 114.

  2012

  Yingqi Hua; Kirill Gorshkov; Yanwen Yang; Wenyi Wang; Nianxiang Zhang; Dennis P. M. Hughes

  Slow down to stay alive: HER4 protects against cellular stress and confers chemoresistance in neuroblastoma

  Cancer. 2012;118(20):5140-5154.

• 115.

  2012

  Xiaohua Su; Young Jin Gi; Deepavali Chakravarti; Io Long Chan; Aijun Zhang; Xuefeng Xia; Kenneth Y. Tsai; Elsa R. Flores

  TAp63 is a master transcriptional regulator of lipid and glucose metabolism

  Cell Metabolism. 2012;16(4):511-525.

• 116.

  2012

  Yaser R. Hussein; Anil K. Sood; Sudeshna Bandyopadhyay; Bassam Albashiti; Assaad Semaan; Zeina Nahleh; Juwon Roh; Hee Dong Han; Gabriel Lopez-Berestein; Rouba Ali-Fehmi

  Clinical and biological relevance of enhancer of zeste homolog 2 in triple-negative breast cancer

  Human Pathology. 2012;43(10):1638-1644.

• 117.

  2012

  Russell J. Schilder; William E. Brady; Heather A. Lankes; James V. Fiorica; Mark S. Shahin; Xun C. Zhou; Robert S. Mannel; Harsh B. Pathak; Wei Hu; R. Katherine Alpaugh; et al.

  Phase II evaluation of dasatinib in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: A gynecologic oncology group study

  Gynecologic Oncology. 2012;127(1):70-74.

• 118.

  2012

  Kate D. Cromwell; Merrick I. Ross; Yan Xing; Jeffrey E. Gershenwald; Richard E. Royal; Anthony Lucci; Jeffrey E. Lee; Janice N. Cormier

  Variability in melanoma post-treatment surveillance practices by country and physician specialty: A systematic review

  Melanoma Research. 2012;22(5):376-385.

• 119.

  2012

  Damian Medici; Raghu Kalluri

  Endothelial-mesenchymal transition and its contribution to the emergence of stem cell phenotype

  Seminars in Cancer Biology. 2012;22(5-6):379-384.

• 120.

  2012

  Lauren Clevenger; Andrew Schrepf; Desire Christensen; Koen DeGeest; David Bender; Amina Ahmed; Michael J. Goodheart; Frank Penedo; David M. Lubaroff; Anil K. Sood; et al.

  Sleep disturbance, cytokines, and fatigue in women with ovarian cancer

  Brain, Behavior, and Immunity. 2012;26(7):1037-1044.

• 121.

  2012

  Aruna Kode; Ioanna Mosialou; Barbara C. Silva; Marie-Therese Rached; Bin Zhou; Ji Wang; Tim M. Townes; Rene Hen; Ronald A. DePinho; X. Edward Guo; et al.

  FOXO1 orchestrates the bone-suppressing function of gut-derived serotonin

  Journal of Clinical Investigation. 2012;122(10):3490-3503.

• 122.

  2012

  Yun-Yong Park; Sung Yun Jung; Nicholas B. Jennings; Cristian Rodriguez-Aguayo; Guang Peng; Se-Ran Lee; Sang Bae Kim; Kyounghyun Kim; Sun-Hee Leem; Shiaw-Yih Lin; et al.

  FOXM1 mediates Dox resistance in breast cancer by enhancing DNA repair

  Carcinogenesis. 2012;33(10):1843-1853.

• 123.

  2012

  Jeffrey E. Gershenwald; Daniel G. Coit; Vernon K. Sondak; John F. Thompson

  The challenge of defining guidelines for sentinel lymph node biopsy in patients with thin primary cutaneous melanomas

  Annals of Surgical Oncology. 2012;19(11):3301-3303.

• 124.

  2012

  Guoyan Liu; Da Yang; Yan Sun; Ilya Shmulevich; Fengxia Xue; Anil K Sood; Wei Zhang

  Differing clinical impact of BRCA1 and BRCA2 mutations in serous ovarian cancer

  Pharmacogenomics. 2012;13(13):1523-1535.

• 125.

  2012

  Hong-Yi Zhou; Shao-Rui Chen; Hee-Sun Byun; Hong Chen; Li Li; Hee-Dong Han; Gabriel Lopez-Berestein; Anil K. Sood; Hui-Lin Pan

  N-methyl-D-aspartate receptor- and calpain-mediated proteolytic cleavage of K⁺-Cl^- cotransporter-2 impairs spinal chloride homeostasis in neuropathic pain

  Journal of Biological Chemistry. 2012;287(40):33853-33864.

• 126.

  2012

  Peter S. Hammerman; Doug Voet; Michael S. Lawrence; Douglas Voet; Rui Jing; Kristian Cibulskis; Andrey Sivachenko; Petar Stojanov; Aaron McKenna; Eric S. Lander; et al.

  Comprehensive genomic characterization of squamous cell lung cancers

  Nature. 2012;489(7417):519-525.

• 127.

  2012

  Xin Lu; Sarit S. Agasti; Claudio Vinegoni; Peter Waterman; Ronald A. Depinho; Ralph Weissleder

  Optochemogenetics (OCG) allows more precise control of genetic engineering in mice with CreER regulators

  Bioconjugate Chemistry. 2012;23(9):1945-1951.

• 128.

  2012

  Chun-Chi Wu; Tsung-Ying Yang; Chang-Tze Ricky Yu; Liem Phan; Cristina Ivan; Anil K. Sood; Shih-Lan Hsu; Mong-Hong Lee

  p53 negatively regulates Aurora A via both transcriptional and posttranslational regulation

  Cell Cycle. 2012;11(18):3433-3442.

• 129.

  2012

  Jian You; Rui Zhang; Chiyi Xiong; Meng Zhong; Maritess Melancon; Sanjay Gupta; Alpa M. Nick; Anil K. Sood; Chun Li

  Effective photothermal chemotherapy using doxorubicin-loaded gold nanospheres that target EphB4 receptors in tumors

  Cancer Research. 2012;72(18):4777-4786.

• 130.

  2012

  Elsa R. Flores; Guillermina Lozano

  The p53 family grows old

  Genes and Development. 2012;26(18):1997-2000.

• 131.

  2012

  Devendra Singh; Joseph Minhow Chan; Pietro Zoppoli; Francesco Niola; Ryan Sullivan; Angelica Castano; Eric Minwei Liu; Jonathan Reichel; Paola Porrati; Serena Pellegatta; et al.

  Transforming fusions of FGFR and TACC genes in human glioblastoma

  Science. 2012;337(6099):1231-1235.

• 132.

  2012

  Yanling Wang; Xiaowen Hu; Joel Greshock; Liang Shen; Xiaojun Yang; Zhongjun Shao; Shun Liang; Janos L. Tanyi; Anil K. Sood; Lin Zhang

  Genomic DNA Copy-Number Alterations of the let-7 Family in Human Cancers

  PLoS ONE. 2012;7(9).

• 133.

  2012

  Young-Ho Ahn; Don L. Gibbons; Deepavali Chakravarti; Chad J. Creighton; Zain H. Rizvi; Henry P. Adams; Alexander Pertsemlidis; Philip A. Gregory; Josephine A. Wright; Gregory J. Goodall; et al.

  ZEB1 drives prometastatic actin cytoskeletal remodeling by downregulating miR-34a expression

  Journal of Clinical Investigation. 2012;122(9):3170-3183.

• 134.

  2012

  Rosa F. Hwang; Todd T. Moore; Maureen Mertens Hattersley; Meghan Scarpitti; Bin Yang; Erik Devereaux; Vijaya Ramachandran; Thiruvengadam Arumugam; Baoan Ji; Craig D. Logsdon; et al.

  Inhibition of the hedgehog pathway targets the tumor-associated stroma in pancreatic cancer

  Molecular Cancer Research. 2012;10(9):1147-1157.

• 135.

  2012

  Lauren Averett Byers; Jing Wang; Monique B. Nilsson; Junya Fujimoto; Pierre Saintigny; John Yordy; Uma Giri; Michael Peyton; You Hong Fan; Lixia Diao; et al.

  Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1

  Cancer Discovery. 2012;2(9):798-811.

• 136.

  2012

  Marievelisse Soto-Salgado; Erick Suárez; Mariela Torres-Cintrón; Curtis A. Pettaway; Vivian Colón; Ana P. Ortiz

  Prostate cancer incidence and mortality among Puerto Ricans: An updated analysis comparing men in Puerto Rico with US racial/ethnic groups

  Puerto Rico Health Sciences Journal. 2012;31(3):107-113.

• 137.

  2012

  Karen R. Rabin; M. Monica Gramatges; Michael J. Borowitz; Shana L. Palla; Xiaodong Shi; Judith F. Margolin; Patrick A. Zweidler-McKay

  Absolute lymphocyte counts refine minimal residual disease-based risk stratification in childhood acute lymphoblastic leukemia

  Pediatric Blood and Cancer. 2012;59(3):468-474.

• 138.

  2012

  Pierre Saintigny; Shaohua Peng; Li Zhang; Banibrata Sen; Ignacio I. Wistuba; Scott M. Lippman; Luc Girard; John D. Minna; John V. Heymach; Faye M. Johnson

  Global evaluation of Eph receptors and ephrins in lung adenocarcinomas identifies EphA4 as an inhibitor of cell migration and invasion

  Molecular Cancer Therapeutics. 2012;11(9):2021-2032.

• 139.

  2012

  Siqing Fu; Yanfang Li; Jie Huang; Tao Liu; Zhen Hong; Aiping Chen; Robert C. Bast; John J. Kavanagh; David M. Gershenson; Anil K. Sood; et al.

  Aurora kinase inhibitor VE 465 synergistically enhances cytotoxicity of carboplatin in ovarian cancer cells through induction of apoptosis and downregulation of histone 3

  Cancer Biology and Therapy. 2012;13(11):1034-1041.

• 140.

  2012

  Benjamin Ellezam; Brett J. Theeler; Tobias Walbert; Aaron G. Mammoser; Craig Horbinski; Bette K. Kleinschmidt-DeMasters; Arie Perry; Vinay Puduvalli; Gregory N. Fuller; Janet M. Bruner; et al.

  Low rate of R132H IDH1 mutation in infratentorial and spinal cord grade II and III diffuse gliomas

  Acta Neuropathologica. 2012;124(3):449-451.

• 141.

  2012

  Jose Luis Lopez Guerra; Daniel Gomez; Yan Zhuang; David S. Hong; John V. Heymach; Stephen G. Swisher; Steven H. Lin; Ritsuko Komaki; James D. Cox; Zhongxing Liao

  Prognostic impact of radiation therapy to the primary tumor in patients with non-small cell lung cancer and oligometastasis at diagnosis

  International Journal of Radiation Oncology Biology Physics. 2012;84(1):e61-e67.

• 142.

  2012

  Amaury G. Dumont; Yanwen Yang; David Reynoso; Daniela Katz; Jonathan C. Trent; Dennis P. Hughes

  Anti-tumor effects of the Notch pathway in gastrointestinal stromal tumors

  Carcinogenesis. 2012;33(9):1674-1683.

• 143.

  2012

  Russell R. Braeuer; Einav Shoshan; Takafumi Kamiya; Menashe Bar-Eli

  The sweet and bitter sides of galectins in melanoma progression

  Pigment Cell and Melanoma Research. 2012;25(5):592-601.

• 144.

  2012

  Zobeida Cruz-Monserrate; Wael R. Abd-Elgaliel; Tobias Grote; Defeng Deng; Baoan Ji; Thiruvengadam Arumugam; Huamin Wang; Ching-Hsuan Tung; Craig D. Logsdon

  Detection of pancreatic cancer tumours and precursor lesions by cathepsin E activity in mouse models

  Gut. 2012;61(9):1315-1322.

• 145.

  2012

  Tiffany A. Doucette; Ling-Yuan Kong; Yuhui Yang; Sherise D. Ferguson; Jinbo Yang; Jun Wei; Wei Qiao; Gregory N. Fuller; Krishna P. Bhat; Kenneth Aldape; et al.

  Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma

  Neuro-Oncology. 2012;14(9):1136-1145.

• 146.

  2012

  E. Susan Amirian; Terri S. Armstrong; Kenneth D. Aldape; Mark R. Gilbert; Michael E. Scheurer

  Predictors of survival among pediatric and adult ependymoma cases: A study using surveillance, epidemiology, and end results data from 1973 to 2007

  Neuroepidemiology. 2012;39(2):116-124.

• 147.

  2012

  Tim R. Fenton; David Nathanson; Claudio Ponte De Albuquerque; Daisuke Kuga; Akio Iwanami; Julie Dang; Huijun Yang; Kazuhiro Tanaka; SueliMieko Oba-Shinjo; Miyuki Uno; et al.

  Resistance to EGF receptor inhibitors in glioblastoma mediated by phosphorylation of the PTEN tumor suppressor at tyrosine 240

  Proceedings of the National Academy of Sciences of the United States of America. 2012;109(35):14164-14169.

• 148.

  2012

  Weiwei Yang; Yan Xia; David Hawke; Xinjian Li; Ji Liang; Dongming Xing; Kenneth Aldape; Tony Hunter; W.K. Alfred Yung; Zhimin Lu

  PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis

  Cell. 2012;150(4):685-696.

• 149.

  2012

  Florian L. Muller; Simona Colla; Elisa Aquilanti; Veronica E. Manzo; Giannicola Genovese; Jaclyn Lee; Daniel Eisenson; Rujuta Narurkar; Pingna Deng; Luigi Nezi; et al.

  Passenger deletions generate therapeutic vulnerabilities in cancer

  Nature. 2012;488(7411):337-342.

• 150.

  2012

  Thiruvengadam Arumugam; Vijaya Ramachandran; Sobeyda B. Gomez; Ann M. Schmidt; Craig D. Logsdon

  S100P-derived RAGE antagonistic peptide reduces tumor growth and metastasis

  Clinical Cancer Research. 2012;18(16):4356-4364.

• 151.

  2012

  Sonia A. Melo; Raghu Kalluri

  Molecular pathways: MicroRNAs as cancer therapeutics

  Clinical Cancer Research. 2012;18(16):4234-4239.

• 152.

  2012

  John A. Jakob; Roland L. Bassett Jr.; Chaan S. Ng; Jonathan L. Curry; Richard W. Joseph; Gladys C. Alvarado; Michelle L. Rohlfs; Jessie Richard; Jeffrey E. Gershenwald; Kevin B. Kim; et al.

  NRAS mutation status is an independent prognostic factor in metastatic melanoma

  Cancer. 2012;118(16):4014-4023.

• 153.

  2012

  Shumei Song; Baoan Ji; Vijaya Ramachandran; Huamin Wang; Margarete Hafley; Craig Logsdon; Robert S. Bresalier

  Overexpressed galectin-3 in pancreatic cancer induces cell proliferation and invasion by binding ras and activating ras signaling

  PLoS ONE. 2012;7(8).

• 154.

  2012

  Ho-Jeong Lee; Hyun-Kyung Yu; Jin-Hyung Ahn; Yong-Keun Park; Yeup Yoon; Jang-Seong Kim; Sun-Jin Kim

  Repeated intravenous infusion of human apolipoprotein(a) kringle V is associated with reversible dose-dependent acute tubulointerstitial nephritis without affecting glomerular filtration function

  Toxicology Letters. 2012;212(3):298-306.

• 155.

  2012

  Dung-Fang Lee; Jie Su; Yen-Sin Ang; Xonia Carvajal-Vergara; Sonia Mulero-Navarro; Carlos F. Pereira; Julian Gingold; Hung-Liang Wang; Ruiying Zhao; Ana Sevilla; et al.

  Regulation of embryonic and induced pluripotency by aurora kinase-p53 signaling

  Cell Stem Cell. 2012;11(2):179-194.

• 156.

  2012

  Ivan Diaz-Padilla; Anais L. Malpica; Lucas Minig; Luis M. Chiva; David M. Gershenson; Antonio Gonzalez-Martin

  Ovarian low-grade serous carcinoma: A comprehensive update

  Gynecologic Oncology. 2012;126(2):279-285.

• 157.

  2012

  P. Hallenborg; S. Feddersen; S. Francoz; I. Murano; U. Sundekilde; R.K. Petersen; V. Akimov; M.V. Olson; G. Lozano; S. Cinti; et al.

  Mdm2 controls CREB-dependent transactivation and initiation of adipocyte differentiation

  Cell Death and Differentiation. 2012;19(8):1381-1389.

• 158.

  2012

  Hai T Tran; Yuan Liu; Amado J Zurita; Ying Lin; Katherine L Baker-Neblett; Anne-Marie Martin; Robert A Figlin; Thomas E Hutson; Cora N Sternberg; Rafael G Amado; et al.

  Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: A retrospective analysis of phase 2 and phase 3 trials

  The Lancet Oncology. 2012;13(8):827-837.

• 159.

  2012

  Vikas Bhardwaj; Yanai Zhan; Maria Angelica Cortez; Kie Kian Ang; David Molkentine; Anupama Munshi; Uma Raju; Ritsuko Komaki; John V. Heymach; James Welsh

  C-met inhibitor MK-8003 radiosensitizes c-met-expressing non-small-cell lung cancer cells with radiation-induced c-met-expression

  Journal of Thoracic Oncology. 2012;7(8):1211-1217.

• 160.

  2012

  K. Rao-Bindal; Z. Zhou; E.S. Kleinerman

  MS-275 sensitizes osteosarcoma cells to Fas ligand-induced cell death by increasing the localization of Fas in membrane lipid rafts

  Cell Death and Disease. 2012;3(8).

• 161.

  2012

  Lorenzo Cohen; Steven W. Cole; Anil K. Sood; Sarah Prinsloo; Clemens Kirschbaum; Jesusa M. G. Arevalo; Nicholas B. Jennings; Shellie Scott; Luis Vence; Qi Wei; et al.

  Depressive symptoms and cortisol rhythmicity predict survival in patients with renal cell carcinoma: Role of inflammatory signaling

  PLoS ONE. 2012;7(8).

• 162.

  2012

  Sun Joo Lee; Sukhen C. Ghosh; Hee Dong Han; Rebecca L. Stone; Justin Bottsford-Miller; De Yue Shen; Edmond J. Auzenne; Alejandro Lopez-Araujo; Chunhua Lu; Masato Nishimura; et al.

  Metronomic activity of CD44-targeted hyaluronic acid-paclitaxel in ovarian carcinoma

  Clinical Cancer Research. 2012;18(15):4114-4121.

• 163.

  2012

  Aditya Raghunathan; Adriana Olar; Hannes Vogel; John R. Parker; Susan C. Coventry; Robert Debski; Constance T. Albarracin; Kenneth D. Aldape; Daniel P. Cahill; Suzanne Z. Powell; et al.

  Isocitrate dehydrogenase 1 R132H mutation is not detected in angiocentric glioma

  Annals of Diagnostic Pathology. 2012;16(4):255-259.

• 164.

  2012

  Xueping Fan; Qinggang Li; Anna Pisarek-Horowitz; Hila Milo Rasouly; Xiangling Wang; Ramon G. Bonegio; Hang Wang; Margaret McLaughlin; Steve Mangos; Raghu Kalluri; et al.

  Inhibitory effects of Robo2 on nephrin: A crosstalk between positive and negative signals regulating podocyte structure

  Cell Reports. 2012;2(1):52-61.

• 165.

  2012

  Eran Hodis; Ian R. Watson; Gregory V. Kryukov; Stefan T. Arold; Marcin Imielinski; Jean-Philippe Theurillat; Elizabeth Nickerson; Daniel Auclair; Liren Li; Chelsea Place; et al.

  A landscape of driver mutations in melanoma

  Cell. 2012;150(2):251-263.

• 166.

  2012

  Ibrahim Tekedereli; S. Neslihan Alpay; Clint D. J. Tavares; Zehra E. Cobanoglu; Tamer S. Kaoud; Ibrahim Sahin; Anil K. Sood; Gabriel Lopez-Berestein; Kevin N. Dalby; Bulent Ozpolat

  Targeted silencing of elongation factor 2 kinase suppresses growth and sensitizes tumors to doxorubicin in an orthotopic model of breast cancer

  PLoS ONE. 2012;7(7).

• 167.

  2012

  Valerie Cortez; Monica Mann; Seshidhar Tekmal; Takayoshi Suzuki; Naoki Miyata; Cristian Rodriguez-Aguayo; Gabriel Lopez-Berestein; Anil K. Sood; Ratna K. Vadlamudi

  Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer

  Breast Cancer Research. 2012;14(4).

• 168.

  2012

  Donna M. Muzny; Matthew N. Bainbridge; Kyle Chang; Huyen H. Dinh; Jennifer A. Drummond; Gerald Fowler; Christie L. Kovar; Lora R. Lewis; Margaret B. Morgan; Irene F. Newsham; et al.

  Comprehensive molecular characterization of human colon and rectal cancer

  Nature. 2012;487(7407):330-337.

• 169.

  2012

  Kristen S. Hill; Ivana Gaziova; Lindsay Harrigal; Yvette A. Guerra; Suimin Qiu; Sarita K. Sastry; Thiruvengadam Arumugam; Craig D. Logsdon; Lisa A. Elferink

  Met receptor tyrosine kinase signaling induces secretion of the angiogenic chemokine interleukin-8/CXCL8 in pancreatic cancer

  PLoS ONE. 2012;7(7).

• 170.

  2012

  Moubin Lin; Jian Gu; Cathy Eng; Lee M. Ellis; Michelle A. Hildebrandt; Jie Lin; Maosheng Huang; George A. Calin; Dingzhi Wang; Raymond N. DuBois; et al.

  Genetic polymorphisms in microRNA-related genes as predictors of clinical outcomes in colorectal adenocarcinoma patients

  Clinical Cancer Research. 2012;18(14):3982-3991.

• 171.

  2012

  N K Agarwal; C-H Chen; H Cho; D R Boulbès; E Spooner; D D Sarbassov

  Rictor regulates cell migration by suppressing RhoGDI2

  Oncogene. 2012.

• 172.

  2012

  Ki Woo Kim; Jose Donato Jr.; Eric D. Berglund; Yun-Hee Choi; Daisuke Kohno; Carol F. Elias; Ronald A. DePinho; Joel K. Elmquist

  FOXO1 in the ventromedial hypothalamus regulates energy balance

  Journal of Clinical Investigation. 2012;122(7):2578-2589.

• 173.

  2012

  Melissa M. Singh; Mary E. Irwin; Yin Gao; Kechen Ban; Ping Shi; Ralph B. Arlinghaus; Hesham M. Amin; Joya Chandra

  Inhibition of the NADPH oxidase regulates heme oxygenase 1 expression in chronic myeloid leukemia

  Cancer. 2012;118(13):3433-3445.

• 174.

  2012

  Simon Robinson; Paul J. Simmons; Michael W. Thomas; Nathalie Brouard; Jeannie A. Javni; Suprita Trilok; Jae-Seung Shim; Hong Yang; David Steiner; William K. Decker; et al.

  Reply to Sackstein

  Experimental Hematology. 2012;40(7):519-520.

• 175.

  2012

  Siqing Fu; Bryan T. Hennessy; Chaan S. Ng; Zhenlin Ju; Kevin R. Coombes; Judith K. Wolf; Anil K. Sood; Charles F. Levenback; Robert L. Coleman; John J. Kavanagh; et al.

  Perifosine plus docetaxel in patients with platinum and taxane resistant or refractory high-grade epithelial ovarian cancer

  Gynecologic Oncology. 2012;126(1):47-53.

• 176.

  2012

  Phillip W. Pisters; Curtis A. Pettaway; Ping Liu; Surena F. Matin; John F. Ward; Dan Leibovici

  Is transureteroureterostomy performed during multi-organ resection for non-urothelial malignancy safe and effective?

  Journal of Surgical Oncology. 2012;106(1):62-65.

• 177.

  2012

  Heping Liu; Ti Zhang; Rong Chen; David J. McConkey; John F. Ward; Steven A. Curley

  Multiple kinase pathways involved in the different de novo sensitivity of pancreatic cancer cell lines to 17-AAG

  Journal of Surgical Research. 2012;176(1):147-153.

• 178.

  2012

  Michael P. Kim; Mark J. Truty; Woonyoung Choi; Ya'An Kang; Xavier Chopin-Lally; Gary E. Gallick; Huamin Wang; David J. McConkey; Rosa Hwang; Craig Logsdon; et al.

  Molecular profiling of direct xenograft tumors established from human pancreatic adenocarcinoma after neoadjuvant therapy

  Annals of Surgical Oncology. 2012;19(SUPPL. 3):S395-S403.

• 179.

  2012

  Jingyao Dai; Jian Gu; Maosheng Huang; Cathy Eng; E. Scott Kopetz; Lee M. Ellis; Ernest Hawk; Xifeng Wu

  GWAS-identified colorectal cancer susceptibility loci associated with clinical outcomes

  Carcinogenesis. 2012;33(7):1327-1331.

• 180.

  2012

  Diane C. Bodurka; Michael T. Deavers; Chunqiao Tian; Charlotte C. Sun; Anais Malpica; Robert L. Coleman; Karen H. Lu; Anil K. Sood; Michael J. Birrer; Robert Ozols; et al.

  Reclassification of serous ovarian carcinoma by a 2-tier system: A Gynecologic Oncology Group study

  Cancer. 2012;118(12):3087-3094.

• 181.

  2012

  Tharangattu N. Narayanan; Bipin K. Gupta; Sajna A. Vithayathil; Rebeca R. Aburto; Sendurai A. Mani; Jaime Taha-Tijerina; Bin Xie; Benny A. Kaipparettu; Suzy V. Torti; Pulickel M. Ajayan

  Hybrid 2D nanomaterials as dual-mode contrast agents in cellular imaging

  Advanced Materials. 2012;24(22):2992-2998.

• 182.

  2012

  James G. Jackson; Vinod Pant; Qin Li; Leslie L. Chang; Alfonso Quintás-Cardama; Daniel Garza; Omid Tavana; Peirong Yang; Taghi Manshouri; Yi Li; et al.

  P53-Mediated Senescence Impairs the Apoptotic Response to Chemotherapy and Clinical Outcome in Breast Cancer

  Cancer Cell. 2012;21(6):793-806.

• 183.

  2012

  Laura D. Nelson; Christian Bender; Heiko Mannsperger; Daniel Buergy; Patryk Kambakamba; Giridhar Mudduluru; Ulrike Korf; Dennis Hughes; Michael W. Van Dyke; Heike Allgayer

  Triplex DNA-binding proteins are associated with clinical outcomes revealed by proteomic measurements in patients with colorectal cancer

  Molecular Cancer. 2012;11.

• 184.

  2012

  Michael A. James; Weidong Wen; Yian Wang; Lauren A. Byers; John V. Heymach; Kevin R. Coombes; Luc Girard; John Minna; Ming You

  Functional characterization of CLPTM1L as a lung cancer risk candidate gene in the 5p15.33 locus

  PLoS ONE. 2012;7(6).

• 185.

  2012

  Behrouz Zand; Robert L. Coleman; Anil K. Sood

  Targeting Angiogenesis in Gynecologic Cancers

  Hematology/Oncology Clinics of North America. 2012;26(3):543-563.

• 186.

  2012

  Adriana Olar; Aditya Raghunathan; Constance T. Albarracin; Kenneth D. Aldape; Daniel P. Cahill III; Suzanne Z. Powell; J. Clay Goodman; Gregory N. Fuller

  Absence of IDH1-R132H mutation predicts rapid progression of nonenhancing diffuse glioma in older adults

  Annals of Diagnostic Pathology. 2012;16(3):161-170.

• 187.

  2012

  Maria Hernandez-Yanez; John V. Heymach; Amado J. Zurita

  Circulating biomarkers in advanced renal cell carcinoma: Clinical applications

  Current Oncology Reports. 2012;14(3):221-229.

• 188.

  2012

  Ignacio Romero Noguera; Charlotte C. Sun; Russell R. Broaddus; Donna Branham; Charles F. Levenback; Pedro T. Ramirez; Anil K. Sood; Robert L. Coleman; David M. Gershenson

  Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant low-grade serous carcinoma of the ovary, peritoneum, or fallopian tube

  Gynecologic Oncology. 2012;125(3):640-645.

• 189.

  2012

  David M. Gershenson; Charlotte C. Sun; Revathy B. Iyer; Anais L. Malpica; John J. Kavanagh; Diane C. Bodurka; Kathleen Schmeler; Michael Deavers

  Hormonal therapy for recurrent low-grade serous carcinoma of the ovary or peritoneum

  Gynecologic Oncology. 2012;125(3):661-666.

• 190.

  2012

  David M. Gershenson

  Current advances in the management of malignant germ cell and sex cord-stromal tumors of the ovary

  Gynecologic Oncology. 2012;125(3):515-517.

• 191.

  2012

  Jean-Pierre Gillet; Anna Maria Calcagno; Sudhir Varma; Ben Davidson; Mari Bunkholt Elstrand; Ram Ganapathi; Aparna A. Kamat; Anil K. Sood; Suresh V. Ambudkar; Michael V. Seiden; et al.

  Multidrug resistance-linked gene signature predicts overall survival of patients with primary ovarian serous carcinoma

  Clinical Cancer Research. 2012;18(11):3197-3206.

• 192.

  2012

  Venkata Lokesh Battula; Yuexi Shi; Kurt W. Evans; Rui-Yu Wang; Erika L. Spaeth; Rodrigo O. Jacamo; Rudy Guerra; Aysegul A. Sahin; Frank C. Marini; Gabriel Hortobagyi; et al.

  Ganglioside GD2 identifies breast cancer stem cells and promotes tumorigenesis

  Journal of Clinical Investigation. 2012;122(6):2066-2078.

• 193.

  2012

  David A. Reardon; Charles A. Conrad; Timothy Cloughesy; Michael D. Prados; Henry S. Friedman; Kenneth D. Aldape; Paul Mischel; Jane Xia; Clivord DiLea; Jerry Huang; et al.

  Phase i study of AEE788, a novel multitarget inhibitor of ErbB- and VEGF-receptor-family tyrosine kinases, in recurrent glioblastoma patients

  Cancer Chemotherapy and Pharmacology. 2012;69(6):1507-1518.

• 194.

  2012

  Ergün Sahin; Ronald A. DePinho

  Axis of ageing: Telomeres, p53 and mitochondria

  Nature Reviews Molecular Cell Biology. 2012;13(6):397-404.

• 195.

  2012

  Katherine S. Panageas; Fabio M. Iwamoto; Timothy F. Cloughesy; Kenneth D. Aldape; Andreana L. Rivera; April F. Eichler; David N. Louis; Nina A. Paleologos; Barbara J. Fisher; Lynn S. Ashby; et al.

  Initial treatment patterns over time for anaplastic oligodendroglial tumors

  Neuro-Oncology. 2012;14(6):761-767.

• 196.

  2012

  Andrew B. Lassman; Fabio M. Iwamoto; Timothy F. Cloughesy; Kenneth D. Aldape; Andreana L. Rivera; April F. Eichler; David N. Louis; Nina A. Paleologos; Barbara J. Fisher; Lynn S. Ashby; et al.

  Response to Weltman and Fleury Malheiros, re Lassman et al.

  Neuro-Oncology. 2012;14(6):677-678.

• 197.

  2012

  Duangmani Thanapprapasr; Wei Hu; Anil K Sood; Robert L Coleman

  Moving beyond vegf for anti-angiogenesis strategies in gynecologic cancer

  Current Pharmaceutical Design. 2012;18(19):2713-2719.

• 198.

  2012

  Simon N. Robinson; Paul J. Simmons; Michael W. Thomas; Nathalie Brouard; Jeannie A. Javni; Suprita Trilok; Jae-Seung Shim; Hong Yang; David Steiner; William K. Decker; et al.

  Ex vivo fucosylation improves human cord blood engraftment in NOD-SCID IL-2Rγ ^null mice

  Experimental Hematology. 2012;40(6):445-456.

• 199.

  2012

  Chia-Hsin Chan; Chien-Feng Li; Wei-Lei Yang; Yuan Gao; Szu-Wei Lee; Zizhen Feng; Hsuan-Ying Huang; Kelvin K.C. Tsai; Leo G. Flores; Yiping Shao; et al.

  The Skp2-SCF E3 ligase regulates akt ubiquitination, glycolysis, herceptin sensitivity, and tumorigenesis

  Cell. 2012;149(5):1098-1111.

• 200.

  2012

  Menashe Bar-Eli

  Back to the embryonic stage: Nodal as a biomarker for breast cancer progression

  Breast Cancer Research. 2012;14(3).

• 201.

  2012

  Xiaoying Liu; Wei Guo; Shuhong Wu; Li Wang; Ji Wang; Bingbing Dai; Edward S. Kim; John V. Heymach; Michael Wang; Luc Girard; et al.

  Antitumor activity of a novel STAT3 inhibitor and redox modulator in non-small cell lung cancer cells

  Biochemical Pharmacology. 2012;83(10):1456-1464.

• 202.

  2012

  Rebecca L. Stone; Vahid Afshar-Kharghan; Anil K. Sood

  The authors reply

  New England Journal of Medicine. 2012;366(19):1840.

• 203.

  2012

  Yuexin Liu; Yan Sun; Russell Broaddus; Jinsong Liu; Anil K. Sood; Ilya Shmulevich; Wei Zhang

  Integrated analysis of gene expression and tumor nuclear image profiles associated with chemotherapy response in serous ovarian carcinoma

  PLoS ONE. 2012;7(5).

• 204.

  2012

  Paolo A. Ascierto; Antonio M. Grimaldi; Brendan Curti; Mark B. Faries; Soldano Ferrone; Keith Flaherty; Bernard A. Fox; Thomas F. Gajewski; Jeffrey E. Gershenwald; Helen Gogas; et al.

  FUTURE PERSPECTIVES IN MELANOMA RESEARCH. Meeting report from the "Melanoma Research: A bridge from Naples to the World. Napoli, December 5 ^th-6 ^th2011"

  Journal of Translational Medicine. 2012;10(1).

• 205.

  2012

  Marianna Sadagurski; Rebecca L. Leshan; Christa Patterson; Aldo Rozzo; Alexandra Kuznetsova; Josh Skorupski; Justin C. Jones; Ronald A. Depinho; Martin G. Myers Jr.; Morris F. White

  IRS2 signaling in LepR-b neurons suppresses FoxO1 to control energy balance independently of leptin action

  Cell Metabolism. 2012;15(5):703-712.

• 206.

  2012

  Yu Kang; Susan K. Lutgendorf; Wei Hu; Steven W. Cole; Anil K. Sood

  Stress related neuroendocrine influences in ovarian cancer

  Current Cancer Therapy Reviews. 2012;8(2):100-109.

• 207.

  2012

  Ke Sai; Shuzhen Wang; Veerakumar Balasubramaniyan; Charles Conrad; Frederick F. Lang; Kenneth Aldape; Slawomir Szymanski; Izabela Fokt; Atreyi Dasgupta; Timothy Madden; et al.

  Induction of cell-cycle arrest and apoptosis in glioblastoma stem-like cells by WP1193, a novel small molecule inhibitor of the JAK2/STAT3 pathway

  Journal of Neuro-Oncology. 2012;107(3):487-501.

• 208.

  2012

  Lauren Marquis; Mai Tran; Woonyoung Choi; I.-Ling Lee; Dennis Huszar; Arlene Siefker-Radtke; Colin P. Dinney; David J. McConkey

  p63 expression correlates with sensitivity to the Eg5 inhibitor AZD4877 in bladder cancer cells

  Cancer Biology and Therapy. 2012;13(7):477-486.

• 209.

  2012

  Peter E. Zage; Riitta Nolo; Wendy Fang; John Stewart; Guillermo Garcia-Manero; Patrick A. Zweidler-Mckay

  Notch pathway activation induces neuroblastoma tumor cell growth arrest

  Pediatric Blood and Cancer. 2012;58(5):682-689.

• 210.

  2012

  Andrea Rabellino; Brandon Carter; Georgia Konstantinidou; Shwu-Yuan Wu; Alessandro Rimessi; Lauren A. Byers; John V. Heymach; Luc Girard; Cheng-Ming Chiang; Julie Teruya-Feldstein; et al.

  The SUMO E3-ligase PIAS1 regulates the tumor suppressor PML and its oncogenic counterpart PML-RARA

  Cancer Research. 2012;72(9):2275-2284.

• 211.

  2012

  Gordon C. Jayson; Daniel J. Hicklin; Lee M. Ellis

  Antiangiogenic therapy-evolving view based on clinical trial results

  Nature Reviews Clinical Oncology. 2012;9(5):297-303.

• 212.

  2012

  Qian Liu; Jinyun Chen; Billy Mai; Christopher Amos; Ann M. Killary; Subrata Sen; Chongjuan Wei; Marsha L. Frazier

  A single-nucleotide polymorphism in tumor suppressor gene SEL1L as a predictive and prognostic marker for pancreatic ductal adenocarcinoma in caucasians

  Molecular Carcinogenesis. 2012;51(5):433-438.

• 213.

  2012

  Hong Mu; Tiffany L. Calderone; Michael A. Davies; Victor G. Prieto; Hua Wang; Gordon B. Mills; Menashe Bar-Eli; Jeffrey E. Gershenwald

  Lysophosphatidic acid induces lymphangiogenesis and IL-8 production in vitro in human lymphatic endothelial cells

  American Journal of Pathology. 2012;180(5):2170-2181.

• 214.

  2012

  Khalida Wani; Terri S. Armstrong; Elizabeth Vera-Bolanos; Aditya Raghunathan; David Ellison; Richard Gilbertson; Brian Vaillant; Stewart Goldman; Roger J. Packer; Maryam Fouladi; et al.

  A prognostic gene expression signature in infratentorial ependymoma

  Acta Neuropathologica. 2012;123(5):727-738.

• 215.

  2012

  Javid Moslehi; Ronald A. Depinho; Ergün Sahin

  Telomeres and mitochondria in the aging heart

  Circulation Research. 2012;110(9):1226-1237.

• 216.

  2012

  Haoqiang Ying; Alec C. Kimmelman; Costas A. Lyssiotis; Sujun Hua; Gerald C. Chu; Eliot Fletcher-Sananikone; Jason W. Locasale; Jaekyoung Son; Hailei Zhang; Jonathan L. Coloff; et al.

  Oncogenic kras maintains pancreatic tumors through regulation of anabolic glucose metabolism

  Cell. 2012;149(3):656-670.

• 217.

  2012

  V. Walia; Y. Yu; D. Cao; M. Sun; J.R. McLean; B.G. Hollier; J. Cheng; S.A. Mani; K. Rao; L. Premkumar; et al.

  Loss of breast epithelial marker hCLCA2 promotes epithelial-to-mesenchymal transition and indicates higher risk of metastasis

  Oncogene. 2012;31(17):2237-2246.

• 218.

  2012

  R. Aimbetov; C.-H. Chen; O. Bulgakova; D. Abetov; A.K. Bissenbaev; R.I. Bersimbaev; D.D. Sarbassov

  Integrity of mTORC2 is dependent on the rictor Gly-934 site

  Oncogene. 2012;31(16):2115-2120.

• 219.

  2012

  Gangxiong Huang; Zhichao Zhou; Hua Wang; Eugenie S. Kleinerman

  CAPER-α alternative splicing regulates the expression of vascular endothelial growth factor ₁₆₅ in Ewing sarcoma cells

  Cancer. 2012;118(8):2106-2116.

• 220.

  2012

  Jaroslaw Daniluk; Yan Liu; Defeng Deng; Jun Chu; Haojie Huang; Sebastian Gaiser; Zobeida Cruz-Monserrate; Huamin Wang; Baoan Ji; Craig D. Logsdon

  An NF-κB pathway-mediated positive feedback loop amplifies Ras activity to pathological levels in mice

  Journal of Clinical Investigation. 2012;122(4):1519-1528.

• 221.

  2012

  Glenda G. Callender; Jeffrey E. Gershenwald; Michael E. Egger; Charles R. Scoggins; Robert C.G. Martin II; Christopher W. Schacherer; Michael J. Edwards; Marshall M. Urist; Merrick I. Ross; Arnold J. Stromberg; et al.

  A novel and accurate computer model of melanoma prognosis for patients staged by sentinel lymph node biopsy: Comparison with the American joint committee on cancer model

  Journal of the American College of Surgeons. 2012;214(4):608-617.

• 222.

  2012

  Chutima Talchai; Shouhong Xuan; Tadahiro Kitamura; Ronald A DePinho; Domenico Accili

  Generation of functional insulin-producing cells in the gut by Foxo1 ablation

  Nature Genetics. 2012;44(4):406-412.

• 223.

  2012

  Marzenna Blonska; Donghyun Joo; Patrick A. Zweidler-McKay; Qingyu Zhao; Xin Lin

  CARMA1 controls Th2 cell-specific cytokine expression through regulating JunB and GATA3 transcription factors

  Journal of Immunology. 2012;188(7):3160-3168.

• 224.

  2012

  Michael Marberger; Stephen J. Freedland; Gerald L. Andriole; Mark Emberton; Curtis Pettaway; Francesco Montorsi; Claudio Teloken; Roger S. Rittmaster; Matthew C. Somerville; Ramiro Castro

  Usefulness of prostate-specific antigen (PSA) rise as a marker of prostate cancer in men treated with dutasteride: Lessons from the REDUCE study

  BJU International. 2012;109(8):1162-1169.

• 225.

  2012

  Hongliang Liu; Qingyi Wei; Jeffrey E. Gershenwald; Victor G. Prieto; Jeffrey E. Lee; Madeleine Duvic; Elizabeth A. Grimm; Li-E Wang

  Influence of single nucleotide polymorphisms in the MMP1 promoter region on cutaneous melanoma progression

  Melanoma Research. 2012;22(2):169-175.

• 226.

  2012

  Ho-Jeong Lee; Hyun-Kyung Yu; John N. Papadopoulos; Seung Wook Kim; Junqin He; Yong-Keun Park; Yeup Yoon; Jang-Seong Kim; Sun Jin Kim

  Targeted antivascular therapy with the apolipoprotein(a) kringle V, rhLK8, inhibits the growth and metastasis of human prostate cancer in an orthotopic nude mouse model

  Neoplasia. 2012;14(4):335-343.

• 227.

  2012

  Stanley R. Hamilton

  Molecular pathology

  Molecular Oncology. 2012;6(2):177-181.

• 228.

  2012

  David M. Gershenson

  Mentoring in gynecologic oncology fellowship training and beyond

  Gynecologic Oncology. 2012;125(1):1-2.

• 229.

  2012

  Jessica L. Berger; Shannon N. Westin; Bryan Fellman; Vijayashri Rallapali; Michael Frumovitz; Pedro T. Ramirez; Anil K. Sood; Pamela T. Soliman

  Modified vertical rectus abdominis myocutaneous flap vaginal reconstruction: An analysis of surgical outcomes

  Gynecologic Oncology. 2012;125(1):252-255.

• 230.

  2012

  Kathleen M. Schmeler; Anil K. Sood; Katherine M. Bell-Mcguinn; Robert L. Coleman; Michael Frumovitz; Yukio Sonoda; Pedro T. Ramirez; David M. Gershenson; Richard R. Barakat; Ginger J. Gardner

  Proceedings from the 9th International Conference on Ovarian Cancer

  Gynecologic Oncology. 2012;125(1):5-7.

• 231.

  2012

  Maria I. Almeida; Milena S. Nicoloso; Lizhi Zeng; Cristina Ivan; Riccardo Spizzo; Roberta Gafà; Lianchun Xiao; Xinna Zhang; Ivan Vannini; Francesca Fanini; et al.

  Strand-specific miR-28-5p and miR-28-3p have distinct effects in colorectal cancer cells

  Gastroenterology. 2012;142(4):886-896.e9.

• 232.

  2012

  Daniel J. Klionsky; Fabio C. Abdalla; Hagai Abeliovich; Robert T. Abraham; Abraham Acevedo-Arozena; Khosrow Adeli; Lotta Agholme; Maria Agnello; Patrizia Agostinis; Julio A. Aguirre-Ghiso; et al.

  Guidelines for the use and interpretation of assays for monitoring autophagy

  Autophagy. 2012;8(4):445-544.

• 233.

  2012

  C. Glenn Begley; Lee M. Ellis

  Drug development: Raise standards for preclinical cancer research

  Nature. 2012;483(7391):531-533.

• 234.

  2012

  Erick Román-Pérez; Patricia Casbas-Hernández; Jason R. Pirone; Jessica Rein; Lisa A. Carey; Ronald A. Lubet; Sendurai A. Mani; Keith D. Amos; Melissa A. Troester

  Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients

  Breast Cancer Research. 2012;14(2).

• 235.

  2012

  Sonia A. Melo; Raghu Kalluri

  Angiogenesis is controlled by miR-27b associated with endothelial tip cells

  Blood. 2012;119(11):2439-2440.

• 236.

  2012

  Jian You; Rui Zhang; Guodong Zhang; Meng Zhong; Yang Liu; Carolyn S. Van Pelt; Dong Liang; Wei Wei; Anil K. Sood; Chun Li

  Photothermal-chemotherapy with doxorubicin-loaded hollow gold nanospheres: A platform for near-infrared light-trigged drug release

  Journal of Controlled Release. 2012;158(2):319-328.

• 237.

  2012

  J.R. Molina; N.K. Agarwal; F.C. Morales; Y. Hayashi; K.D. Aldape; G. Cote; M.-M. Georgescu

  PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastoma

  Oncogene. 2012;31(10):1264-1274.

• 238.

  2012

  Kyoichiro Tsuchiya; Jun Tanaka; Yu Shuiqing; Carrie L. Welch; Ronald A. Depinho; Ira Tabas; Alan R. Tall; Ira J. Goldberg; Domenico Accili

  FoxOs integrate pleiotropic actions of insulin in vascular endothelium to protect mice from atherosclerosis

  Cell Metabolism. 2012;15(3):372-381.

• 239.

  2012

  Valerae Olive Lewis; Susan A. Scherl; Mary I. O'Connor

  Women in orthopaedics - Way behind the number curve

  Journal of Bone and Joint Surgery - Series A. 2012;94(5):e30.

• 240.

  2012

  Wenjun Guo; Zuzana Keckesova; Joana Liu Donaher; Tsukasa Shibue; Verena Tischler; Ferenc Reinhardt; Shalev Itzkovitz; Aurelia Noske; Ursina Zürrer-Härdi; George Bell; et al.

  Slug and Sox9 cooperatively determine the mammary stem cell state

  Cell. 2012;148(5):1015-1028.

• 241.

  2012

  Zhihu Ding; Chang-Jiun Wu; Mariela Jaskelioff; Elena Ivanova; Maria Kost-Alimova; Alexei Protopopov; Gerald C. Chu; Guocan Wang; Xin Lu; Emma S. Labrot; et al.

  Telomerase reactivation following telomere dysfunction yields murine prostate tumors with bone metastases

  Cell. 2012;148(5):896-907.

• 242.

  2012

  Hubert M. Chodkiewicz; Philip R. Cohen; Kevin B. Kim; Doina Ivan; Jeffrey E. Gershenwald

  A lupus-like reaction to subcutaneous interferon-α at injection sites

  Journal of Drugs in Dermatology. 2012;11(3):393-398.

• 243.

  2012

  Ya-Chen Tina Shih; John F. Ward; Curtis A. Pettaway; Ying Xu; Surena F. Matin; John W. Davis; Benjamin P. Thompson; Linda S. Elting

  Comparative effectiveness, cost, and utilization of radical prostatectomy among young men within managed care insurance plans

  Value in Health. 2012;15(2):367-375.

• 244.

  2012

  Steven W. Cole; Anil K. Sood

  Molecular pathways: Beta-adrenergic signaling in cancer

  Clinical Cancer Research. 2012;18(5):1201-1206.

• 245.

  2012

  Michael Frumovitz; Maya L. Kriseman; Charlotte C. Sun; Jennifer Blumenthal-Barby; Anil K. Sood; Diane C. Bodurka; Pamela T. Soliman

  Unverifiable accomplishments and publications on applications for gynecologic oncology fellowships

  Obstetrics and Gynecology. 2012;119(3):504-508.

• 246.

  2012

  Da Yang; Sofia Khan; Yan Sun; Kenneth Hess; Ilya Shmulevich; Anil K. Sood; Wei Zhang

  Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer

  Obstetrical and Gynecological Survey. 2012;67(3):164-165.

• 247.

  2012

  Genevieve M. Boland; Jeffrey E. Gershenwald

  Sentinel lymph node biopsy in melanoma

  Cancer Journal. 2012;18(2):185-191.

• 248.

  2012

  Hikaru Sugimoto; Valerie S. LeBleu; Dattatreyamurty Bosukonda; Peter Keck; Gangadhar Taduri; Wibke Bechtel; Hirokazu Okada; William Carlson Jr.; Philippe Bey; Mary Rusckowski; et al.

  Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis

  Nature Medicine. 2012;18(3):396-404.

• 249.

  2012

  Mikhail G. Kolonin; Kurt W. Evans; Sendurai A. Mani; Richard H. Gomer

  Alternative origins of stroma in normal organs and disease

  Stem Cell Research. 2012;8(2):312-323.

• 250.

  2012

  Stephen E. Ullrich; Scott N. Byrne

  The immunologic revolution: Photoimmunology

  Journal of Investigative Dermatology. 2012;132(3 PART 2):896-905.

• 251.

  2012

  Patrick P. Lin; Mohammed D. Alfawareh; Akihiko Takeuchi; Bryan S. Moon; Valerae O. Lewis

  Sixty percent 10-year survival of patients with chondrosarcoma after local recurrence

  Clinical Orthopaedics and Related Research. 2012;470(3):670-676.

• 252.

  2012

  David M. Gershenson

  Treatment of ovarian cancer in young women

  Clinical Obstetrics and Gynecology. 2012;55(1):65-74.

• 253.

  2012

  Scott E. Woodman; Alexander J. Lazar; Kenneth D. Aldape; Michael A. Davies

  New strategies in melanoma: Molecular testing in advanced disease

  Clinical Cancer Research. 2012;18(5):1195-1200.

• 254.

  2012

  Ian Lee; Patricia S. Fox; Sherise D. Ferguson; Roland Bassett; Ling-Yuan Kong; Christopher W. Schacherer; Jeffrey E. Gershenwald; Elizabeth A. Grimm; Gregory N. Fuller; Amy B. Heimberger

  The Expression of p-STAT3 in Stage IV Melanoma: Risk of CNS Metastasis and Survival

  Oncotarget. 2012;3(3):336-344.

• 255.

  2012

  Li Li; Xue-Hong Cao; Shao-Rui Chen; Hee-Dong Han; Gabriel Lopez-Berestein; Anil K. Sood; Hui-Lin Pan

  Up-regulation of Cavβ₃ subunit in primary sensory neurons increases voltage-activated Ca²⁺ channel activity and nociceptive input in neuropathic pain

  Journal of Biological Chemistry. 2012;287(8):6002-6013.

• 256.

  2012

  Jian Hu; Soyoon Sarah Hwang; Marc Liesa; Boyi Gan; Ergun Sahin; Mariela Jaskelioff; Zhihu Ding; Haoqiang Ying; Adam T. Boutin; Hailei Zhang; et al.

  Antitelomerase therapy provokes ALT and mitochondrial adaptive mechanisms in cancer

  Cell. 2012;148(4):651-663.

• 257.

  2012

  Rebecca L. Stone; Alpa M. Nick; Iain A. McNeish; Frances Balkwill; Hee Dong Han; Justin Bottsford-Miller; Rajesha Rupaimoole; Guillermo N. Armaiz-Pena; Chad V. Pecot; Jermaine Coward; et al.

  Paraneoplastic thrombocytosis in ovarian cancer

  New England Journal of Medicine. 2012;366(7):610-618.

• 258.

  2012

  Gangxiong Huang; Kazumasa Nishimoto; Zhichao Zhou; Dennis Hughes; Eugenie S. Kleinerman

  miR-20a encoded by the miR-17-92 cluster increases the metastatic potential of osteosarcoma cells by regulating fas expression

  Cancer Research. 2012;72(4):908-916.

• 259.

  2012

  Michal Mego; Sendurai A. Mani; Bang-Ning Lee; Changping Li; Kurt W. Evans; Evan N. Cohen; Hui Gao; Summer A. Jackson; Antonio Giordano; Gabriel N. Hortobagyi; et al.

  Expression of epithelial-mesenchymal transition-inducing transcription factors in primary breast cancer: The effect of neoadjuvant therapy

  International Journal of Cancer. 2012;130(4):808-816.

• 260.

  2012

  David A. Engler; Sumeet Gupta; Whitfield B. Growdon; Ronny I. Drapkin; Mai Nitta; Petra A. Sergent; Serena F. Allred; Jenny Gross; Michael T. Deavers; Wen-Lin Kuo; et al.

  Genome wide DNA copy number analysis of serous type ovarian carcinomas identifies genetic markers predictive of clinical outcome

  PLoS ONE. 2012;7(2).

• 261.

  2012

  Hiroshi Katayama; Jin Wang; Warapen Treekitkarnmongkol; Hidehiko Kawai; Kaori Sasai; Hui Zhang; Hua Wang; Henry P. Adams; Shoulei Jiang; Sandip N. Chakraborty; et al.

  Aurora Kinase-A Inactivates DNA Damage-Induced Apoptosis and Spindle Assembly Checkpoint Response Functions of p73

  Cancer Cell. 2012;21(2):196-211.

• 262.

  2012

  Nathan T. Ihle; Lauren A. Byers; Edward S. Kim; Pierre Saintigny; J. Jack Lee; George R. Blumenschein; Anne Tsao; Suyu Liu; Jill E. Larsen; Jing Wang; et al.

  Effect of KRAS oncogene substitutions on protein behavior: Implications for signaling and clinical outcome

  Journal of the National Cancer Institute. 2012;104(3):228-239.

• 263.

  2012

  Chen Huang; Zhengjun Qiu; Liwei Wang; Zhihai Peng; Zhiliang Jia; Craig D. Logsdon; Xiangdong Le; Daoyan Wei; Suyun Huang; Keping Xie

  A novel FoxM1-caveolin signaling pathway promotes pancreatic cancer invasion and metastasis

  Cancer Research. 2012;72(3):655-665.

• 264.

  2012

  Kebin Zhang; Ling Li; Yajuan Qi; Xiaoping Zhu; Boyi Gan; Ronald A. DePinho; Travis Averitt; Shaodong Guo

  Hepatic suppression of Foxo1 and Foxo3 causes hypoglycemia and hyperlipidemia in mice

  Endocrinology. 2012;153(2):631-646.

• 265.

  2012

  Sun-Jin Kim; Jang Seong Kim; Seung Wook Kim; Seok Joong Yun; Junqin He; Emily Brantley; Dominic Fan; Panja Strickner; François Lehembre; Urs Regenass; et al.

  Antivascular therapy for multidrug-resistant ovarian tumors by macitentan, a dual endothelin receptor antagonist

  Translational Oncology. 2012;5(1):39-47.

• 266.

  2012

  Benjamin Ellezam; Brett J. Theeler; Rajyalakshmi Luthra; Adekunle M. Adesina; Kenneth D. Aldape; Mark R. Gilbert

  Recurrent PIK3CA mutations in rosette-forming glioneuronal tumor

  Acta Neuropathologica. 2012;123(2):285-287.

• 267.

  2012

  Sameer Agnihotri; Aaron S. Gajadhar; Christian Ternamian; Thierry Gorlia; Kristin L. Diefes; Paul S. Mischel; Joanna Kelly; Gail McGown; Mary Thorncroft; Brett L. Carlson; et al.

  Alkylpurine-DNA-N-glycosylase confers resistance to temozolomide in xenograft models of glioblastoma multiforme and is associated with poor survival in patients (Journal of Clinical Investigation (2012) 122, 1, (253-266) DOI: 10.1172/JCI59334)

  Journal of Clinical Investigation. 2012;122(2):782.

• 268.

  2012

  Amal Melhem-Bertrandt; Anil K. Sood

  New directions in reducing stress effects on cancer

  Cancer Prevention Research. 2012;5(2):147-149.

• 269.

  2012

  Alejandro G. Levy; Peter E. Zage; Lauren J. Akers; Maurizio L. Ghisoli; Zhao Chen; Wendy Fang; Sankaranarayanan Kannan; Timothy Graham; Lizhi Zeng; Anna R. Franklin; et al.

  The combination of the novel glycolysis inhibitor 3-BrOP and rapamycin is effective against neuroblastoma

  Investigational New Drugs. 2012;30(1):191-199.

• 270.

  2012

  Sherry Y. Wu; Anil K. Sood

  New roles opined for OPCML

  Cancer Discovery. 2012;2(2):115-116.

• 271.

  2012

  Mert Erkan; Guido Adler; Minoti V. Apte; Max G. Bachem; Malte Buchholz; Sönke Detlefsen; Irene Esposito; Helmut Friess; Thomas M. Gress; Hans-Joerg Habisch; et al.

  StellaTUM: Current consensus and discussion on pancreatic stellate cell research

  Gut. 2012;61(2):172-178.

• 272.

  2012

  Anil K. Sood; Robert L. Coleman; Lee M. Ellis

  Moving beyond anti-vascular endothelial growth factor therapy in ovarian cancer

  Journal of Clinical Oncology. 2012;30(4):345-347.

• 273.

  2012

  Tina Cascone; John V. Heymach

  Targeting the angiopoietin/Tie2 pathway: Cutting tumor vessels with a double-edged sword?

  Journal of Clinical Oncology. 2012;30(4):441-444.

• 274.

  2012

  Wei Zhang; Da Yang; Anil K. Sood

  BRCA1 and BRCA2 mutations in ovarian cancer - Reply

  JAMA - Journal of the American Medical Association. 2012;307(4):360-361.

• 275.

  2012

  Ross A. Poché; Ramaswamy Sharma; Monica D. Garcia; Aya M. Wada; Mark J. Nolte; Ryan S. Udan; Ji-Hye Paik; Ronald A. DePinho; John D. Bartlett; Mary E. Dickinson

  Transcription factor FoxO1 is essential for enamel biomineralization

  PLoS ONE. 2012;7(1).

• 276.

  2012

  Vesselina G. Cooke; Valerie S. LeBleu; Doruk Keskin; Zainab Khan; Joyce T. O'Connell; Yingqi Teng; Michael B. Duncan; Liang Xie; Genta Maeda; Sylvia Vong; et al.

  Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway

  Cancer Cell. 2012;21(1):66-81.

• 277.

  2012

  Woonyoung Choi; Jay B. Shah; Mai Tran; Robert Svatek; Lauren Marquis; I-Ling Lee; Dasom Yu; Liana Adam; Sijin Wen; Yu Shen; et al.

  p63 expression defines a lethal subset of muscle-invasive bladder cancers

  PLoS ONE. 2012;7(1).

• 278.

  2012

  Sameer Agnihotri; Aaron S. Gajadhar; Christian Ternamian; Thierry Gorlia; Kristin L. Diefes; Paul S. Mischel; Joanna Kelly; Gail McGown; Mary Thorncroft; Brett L. Carlson; et al.

  Alkylpurine - DNA - N-glycosylase confers resistance to temozolomide in xenograft models of glioblastoma multiforme and is associated with poor survival in patients

  Journal of Clinical Investigation. 2012;122(1):253-266.

• 279.

  2012

  Qingqing Ding; Chun-Ju Chang; Xiaoming Xie; Weiya Xia; Jer-Yen Yang; Shao-Chun Wang; Yan Wang; Jiahong Xia; Libo Chen; Changchun Cai; et al.

  APOBEC3G promotes liver metastasis in an orthotopic mouse model of colorectal cancer and predicts human hepatic metastasis (Journal of Clinical Investigation (2012) 122, 1 (419) DOI:10.1172/JCI61734)

  Journal of Clinical Investigation. 2012;122(1):419.

• 280.

  2012

  Shervin M. Shirvani; Ritsuko Komaki; John V. Heymach; Frank V. Fossella; Joe Y. Chang

  Positron emission tomography/computed tomography-guided intensity-modulated radiotherapy for limited-stage small-cell lung cancer

  International Journal of Radiation Oncology Biology Physics. 2012;82(1):e91-e97.

• 281.

  2012

  An-Jou Chen; Ji-Hye Paik; Hailei Zhang; Sachet A. Shukla; Richard Mortensen; Jian Hu; Haoqiang Ying; Baoli Hu; Jessica Hurt; Natalie Farny; et al.

  STAR RNA-binding protein Quaking suppresses cancer via stabilization of specific miRNA

  Genes and Development. 2012;26(13):1459-1472.

• 282.

  2012

  Don N. Ho; Nathan Kohler; Aruna Sigdel; Raghu Kalluri; Jeffrey R. Morgan; Chenjie Xu; Shouheng Sun

  Penetration of endothelial cell coated multicellular tumor spheroids by iron oxide nanoparticles

  Theranostics. 2012;2(1):66-75.

• 283.

  2012

  Ross A Poché; Ramaswamy Sharma; Monica D Garcia; Aya M Wada; Mark J Nolte; Ryan S Udan; Ji-Hye Paik; Ronald A DePinho; John D Bartlett; Mary E Dickinson

  Transcription factor FoxO1 is essential for enamel biomineralization.

  PloS one. 2012;7(1):e30357.

• 284.

  2012

  Joaquin Mateo; John V. Heymach; Amado J. Zurita

  Circulating biomarkers of response to sunitinib in gastroenteropancreatic neuroendocrine tumors: Current data and clinical outlook

  Molecular Diagnosis and Therapy. 2012;16(3):151-161.

• 285.

  2012

  Yong He; Zhen Zhou; Wayne L. Hofstetter; Yanbin Zhou; Wenxian Hu; Chengcheng Guo; Li Wang; Wei Guo; Apar Pataer; Arlene M. Correa; et al.

  Aberrant expression of proteins involved in signal transduction and DNA repair pathways in lung cancer and their association with clinical parameters

  PLoS ONE. 2012;7(2).

• 286.

  2012

  Moubin Lin; Cathy Eng; Ernest T. Hawk; Maosheng Huang; Anthony J. Greisinger; Jian Gu; Lee M. Ellis; Xifeng Wu; Jie Lin

  Genetic variants within ultraconserved elements and susceptibility to right- and left-sided colorectal adenocarcinoma

  Carcinogenesis. 2012;33(4):841-847.

• 287.

  2012

  David Z Chang; Ying Ma; Baoan Ji; Yan Liu; Patrick Hwu; James L Abbruzzese; Craig Logsdon; Huamin Wang

  Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression

  Journal of Hematology and Oncology. 2012;5.

• 288.

  2012

  Yujun Song; Yuanqing Zhang; Paul E. Bernard; James M. Reuben; Naoto T. Ueno; Ralph B. Arlinghaus; Youli Zu; Lidong Qin

  Multiplexed volumetric bar-chart chip for point-of-care diagnostics

  Nature Communications. 2012;3.

• 289.

  2012

  Maurisa F. Riley; Guillermina Lozano

  The Many Faces of MDM2 Binding Partners

  Genes and Cancer. 2012;3(3-4):226-239.

• 290.

  2012

  Robert L. Satcher; Patrick Lin; Nursat Harun; Lei Feng; Bryan S. Moon; Valerae O. Lewis

  Surgical management of appendicular skeletal metastases in thyroid carcinoma

  International Journal of Surgical Oncology. 2012;2012.

• 291.

  2012

  G. Blandino; W. Deppert; P. Hainaut; A. Levine; G. Lozano; M. Olivier; V. Rotter; K. Wiman; M. Oren

  Mutant p53 protein, master regulator of human malignancies: A report on the fifth Mutant p53 Workshop

  Cell Death and Differentiation. 2012;19(1):180-183.

• 292.

  2012

  Farshid Dayyani; Curtis A. Pettaway; Ashish M. Kamat; Mark F. Munsell; Kanishka Sircar; Lance C. Pagliaro

  Retrospective analysis of survival outcomes and the role of cisplatin-based chemotherapy in patients with urethral carcinomas referred to medical oncologists ^{{star, open}}

  Urologic Oncology: Seminars and Original Investigations. 2012.

• 293.

  2012

  Gavin P. Dunn; Mikael L. Rinne; Jill Wykosky; Giannicola Genovese; Steven N. Quayle; Ian F. Dunn; Pankaj K. Agarwalla; Milan G. Chheda; Benito Campos; Alan Wang; et al.

  Emerging insights into the molecular and cellular basis of glioblastoma

  Genes and Development. 2012;26(8):756-784.

• 294.

  2012

  Ronald DePinho

  Straight talk with... Ronald DePinho. Interview by Rebecca Hersher.

  Nature medicine. 2012;18(1):9.

• 295.

  2012

  A.J. Zurita; E. Jonasch; X. Wang; M. Khajavi; S. Yan; D.Z. Du; L. Xu; M.H. Herynk; K.S. Mckee; H.T. Tran; et al.

  A cytokine and angiogenic factor (CAF) analysis in plasma for selection of sorafenib therapy in patients with metastatic renal cell carcinoma

  Annals of Oncology. 2012;23(1):46-52.

• 296.

  2012

  Yunfei Zhou; Federico Tozzi; Jinyu Chen; Fan Fan; Ling Xia; Jinrong Wang; Guang Gao; Aijun Zhang; Xuefeng Xia; Heather Brasher; et al.

  Intracellular ATP levels are a pivotal determinant of chemoresistance in colon cancer cells

  Cancer Research. 2012;72(1):304-314.

• 297.

  2012

  Gangxiong Huang; Ling Yu; Laurence J. N. Cooper; Mario Hollomon; Helen Huls; Eugenie S. Kleinerman

  Genetically modified T cells targeting interleukin-11 receptor α-chain kill human osteosarcoma cells and induce the regression of established osteosarcoma lung metastases

  Cancer Research. 2012;72(1):271-281.

• 298.

  2012

  Ronald DePinho

  Straight talk with..

  Nature Medicine. 2012;18(1):9.

• 299.

  2012

  Mark W. Clemens; Edward I. Chang; Jesse C. Selber; Valerae O. Lewis; Scott D. Oates; David W. Chang

  Composite extremity and trunk reconstruction with vascularized fibula flap in postoncologic bone defects: A 10-year experience

  Plastic and Reconstructive Surgery. 2012;129(1):170-178.

• 300.

  2012

  Dos D. Sarbassov; Olga Bulgakova; Rakhmet I. Bersimbaev; Tattym Shaiken

  Isolation of the mTOR complexes by affinity purification

  Methods in Molecular Biology. 2012;821:59-74.

• 301.

  2012

  Erick Román-Pérez; Patricia Casbas-Hernández; Jason R Pirone; Jessica Rein; Lisa A Carey; Ronald A Lubet; Sendurai A Mani; Keith D Amos; Melissa A Troester

  Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients.

  Breast cancer research : BCR. 2012;14(2):R51.

• 302.

  2012

  Peiying Yang; Carrie Cartwright; Ekem Efuet; Stanley R. Hamilton; Ignacio Ivan Wistuba; David Menter; Crandell Addington; Imad Shureqi; Robert A. Newman

  Cellular location and expression of Na ⁺, K ⁺-ATPase α subunits affect the anti-proliferative activity of oleandrin

  Molecular Carcinogenesis. 2012.

• 303.

  2012

  Malgorzata Kloc; Neelam Tejpal; Jitinderpal Sidhu; Malathesha Ganachari; Pedro Flores-Villanueva; Nicholas B. Jennings; Anil K. Sood; Jacek Z. Kubiak; Rafik M. Ghobrial

  Inverse relationship between TCTP/RhoA and p53//cyclin A/actin expression in ovarian cancer cells

  Folia Histochemica et Cytobiologica. 2012;50(3):358-367.

• 304.

  2012

  David J. McConkey; Matthew White; Wudan Yan

  HDAC Inhibitor Modulation of Proteotoxicity as a Therapeutic Approach in Cancer

  Advances in Cancer Research. 2012;116:131-163.

• 305.

  2012

  Jing Li; Erik Sulman; Kenneth Aldape

  Molecular biology of brain tumors

  Handbook of Clinical Neurology. 2012;104:23-34.

• 306.

  2012

  Susan K. Lutgendorf; Koen De Geest; David Bender; Amina Ahmed; Michael J. Goodheart; Laila Dahmoush; M. Bridget Zimmerman; Frank J. Penedo; Joseph A. Lucci III; Parvin Ganjei-Azar; et al.

  Social influences on clinical outcomes of patients with ovarian cancer

  Journal of Clinical Oncology. 2012;30(23):2885-2890.

• 307.

  2012

  Ching-Wei D. Tzeng; Thomas A. Aloia; Jean-Nicolas Vauthey; George J. Chang; Lee M. Ellis; Barry W. Feig; Steven A. Curley; John M. Skibber; Eddie K. Abdalla; Y.Nancy You; et al.

  Morbidity of Staged Proctectomy After Hepatectomy for Colorectal Cancer: A Matched Case-Control Analysis

  Annals of Surgical Oncology. 2012:1-9.

• 308.

  2011

  Shu Lin; Lan Yu; Junhua Yang; Zhao Liu; Bijal Karia; Alexander J. R. Bishop; James Jackson; Guillermina Lozano; John A. Copland; Xiaoxin Mu; et al.

  Mutant p53 disrupts role of ShcA protein in balancing smad protein-dependent and -independent signaling activity of transforming growth factor-β (TGF-β)

  Journal of Biological Chemistry. 2011;286(51):44023-44034.

• 309.

  2011

  Krishna P.L. Bhat; Katrina L. Salazar; Veerakumar Balasubramaniyan; Khalida Wani; Lindsey Heathcock; Faith Hollingsworth; Johanna D. James; Joy Gumin; Kristin L. Diefes; Se Hoon Kim; et al.

  The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma

  Genes and Development. 2011;25(24):2594-2609.

• 310.

  2011

  Sanjay Shete; Ching C. Lau; Richard S. Houlston; Elizabeth B. Claus; Jill Barnholtz-Sloan; Rose Lai; Dora Il'yasova; Joellen Schildkraut; Siegal Sadetzki; Christoffer Johansen; et al.

  Genome-wide high-density SNP linkage search for glioma susceptibility loci: Results from the gliogene consortium

  Cancer Research. 2011;71(24):7568-7575.

• 311.

  2011

  Matija Snuderl; Ladan Fazlollahi; Long P. Le; Mai Nitta; Boryana H. Zhelyazkova; Christian J. Davidson; Sara Akhavanfard; Daniel P. Cahill; Kenneth D. Aldape; Rebecca A. Betensky; et al.

  Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma

  Cancer Cell. 2011;20(6):810-817.

• 312.

  2011

  Al B. Benson III; Stanley R. Hamilton

  Path toward prognostication and prediction: An evolving matrix

  Journal of Clinical Oncology. 2011;29(35):4599-4601.

• 313.

  2011

  Hong Wu; Rami Abou Zeinab; Elsa R. Flores; Roger P. Leng

  Pirh2, a ubiquitin E3 ligase, inhibits p73 transcriptional activity by promoting its ubiquitination

  Molecular Cancer Research. 2011;9(12):1780-1790.

• 314.

  2011

  Albert Lai; Samir Kharbanda; Whitney B. Pope; Anh Tran; Orestes E. Solis; Franklin Peale; William F. Forrest; Kanan Pujara; Jose A. Carrillo; Ajay Pandita; et al.

  Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin

  Journal of Clinical Oncology. 2011;29(34):4482-4490.

• 315.

  2011

  Chad V. Pecot; Farideh Z. Bischoff; Julie Ann Mayer; Karina L. Wong; Tam Pham; Justin Bottsford-Miller; Rebecca L. Stone; Yvonne G. Lin; Padmavathi Jaladurgam; Ju Won Roh; et al.

  A novel platform for detection of CK ⁺ and CK ^- CTCs

  Cancer Discovery. 2011;1(7):580-586.

• 316.

  2011

  Baoan Ji; Craig D. Logsdon

  Digesting new information about the role of trypsin in pancreatitis

  Gastroenterology. 2011;141(6):1972-1975.

• 317.

  2011

  Christopher I. Amos; Li-E Wang; Jeffrey E. Lee; Jeffrey E. Gershenwald; Wei V. Chen; Shenying Fang; Roman Kosoy; Mingfeng Zhang; Abrar A. Qureshi; Selina Vattathil; et al.

  Genome-wide association study identifies novel loci predisposing to cutaneous melanoma

  Human Molecular Genetics. 2011;20(24):5012-5023.

• 318.

  2011

  David B. Jackson; Anil K. Sood

  Personalized cancer medicine-advances and socio-economic challenges

  Nature Reviews Clinical Oncology. 2011;8(12):735-741.

• 319.

  2011

  Weiwei Yang; Yan Xia; Haitao Ji; Yanhua Zheng; Ji Liang; Wenhua Huang; Xiang Gao; Kenneth Aldape; Zhimin Lu

  Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation

  Nature. 2011;480(7375):118-122.

• 320.

  2011

  Angela N. Bartley; Hui Yao; Bedia A. Barkoh; Cristina Ivan; Bal M. Mishra; Asif Rashid; George A. Calin; Rajyalakshmi Luthra; Stanley R. Hamilton

  Complex patterns of altered microRNA expression during the adenoma-adenocarcinoma sequence for microsatellite-stable colorectal cancer

  Clinical Cancer Research. 2011;17(23):7283-7293.

• 321.

  2011

  Young-Ah Suh; Sean M. Post; Ana C. Elizondo-Fraire; Daniela R. Maccio; James G. Jackson; Adel K. El-Naggar; Carolyn Van Pelt; Tamara Terzian; Guillermina Lozano

  Multiple stress signals activate mutant p53 in vivo

  Cancer Research. 2011;71(23):7168-7175.

• 322.

  2011

  Richard L.R. White Jr.; Gregory D. Ayers; Virginia H. Stell; Shouluan Ding; Jeffrey E. Gershenwald; Jonathan C. Salo; Barbara A. Pockaj; Richard Essner; Mark Faries; Kim James Charney; et al.

  Factors predictive of the status of sentinel lymph nodes in melanoma patients from a large multicenter database

  Annals of Surgical Oncology. 2011;18(13):3593-3600.

• 323.

  2011

  E. David Crawford; Judd W. Moul; Kyle O. Rove; Curtis A. Pettaway; Lois E. Lamerato; Alexa Hughes

  Prostate-specific antigen 1.5-4.0 ng/mL: A diagnostic challenge and danger zone

  BJU International. 2011;108(11):1743-1749.

• 324.

  2011

  Wael R. Abd-Elgaliel; Zobeida Cruz-Monserrate; Craig D. Logsdon; Ching-Hsuan Tung

  Molecular imaging of Cathepsin E-positive tumors in mice using a novel protease-activatable fluorescent probe

  Molecular BioSystems. 2011;7(12):3207-3213.

• 325.

  2011

  Sylvia Vong; Raghu Kalluri

  The Role of Stromal Myofibroblast and Extracellular Matrix in Tumor Angiogenesis

  Genes and Cancer. 2011;2(12):1139-1145.

• 326.

  2011

  Valerie S. Lebleu; Raghu Kalluri

  Blockade of PDGF receptor signaling reduces myofibroblast number and attenuates renal fibrosis

  Kidney International. 2011;80(11):1119-1121.

• 327.

  2011

  Triona Ni Chonghaile; Kristopher A. Sarosiek; Thanh-Trang Vo; Jeremy A. Ryan; Anupama Tammareddi; Victoria Del Gaizo Moore; Jing Deng; Kenneth C. Anderson; Paul Richardson; Yu-Tzu Tai; et al.

  Pretreatment mitochondrial priming correlates with clinical response to cytotoxic chemotherapy

  Science. 2011;334(6059):1129-1133.

• 328.

  2011

  D. Bose; L.J. Zimmerman; M. Pierobon; E. Petricoin; F. Tozzi; A. Parikh; F. Fan; N. Dallas; L. Xia; P. Gaur; et al.

  Chemoresistant colorectal cancer cells and cancer stem cells mediate growth and survival of bystander cells

  British Journal of Cancer. 2011;105(11):1759-1767.

• 329.

  2011

  Kazuo Konishi; Yoshiyuki Watanabe; Lanlan Shen; Yi Guo; Ryan J. Castoro; Kimie Kondo; Woonbok Chung; Saira Ahmed; Jaroslav Jelinek; Yanis A. Boumber; et al.

  DNA methylation profiles of primary colorectal carcinoma and matched liver metastasis

  PLoS ONE. 2011;6(11).

• 330.

  2011

  Chien-Hung Chen; Dos D. Sarbassov

  The mTOR (mammalian target of rapamycin) kinase maintains integrity of mTOR complex 2

  Journal of Biological Chemistry. 2011;286(46):40386-40394.

• 331.

  2011

  Nathalie Sphyris; Sendurai A. Mani

  PIgR: Frenemy of inflammation, EMT, and HCC progression

  Journal of the National Cancer Institute. 2011;103(22):1644-1645.

• 332.

  2011

  Fernanda I. Staquicini; Marina Cardó-Vila; Mikhail G. Kolonin; Martin Trepel; Julianna K. Edwards; Diana N. Nunes; Anna Sergeeva; Eleni Efstathiou; Jessica Sun; Nalvo F. Almeida; et al.

  Vascular ligand-receptor mapping by direct combinatorial selection in cancer patients

  Proceedings of the National Academy of Sciences of the United States of America. 2011;108(46):18637-18642.

• 333.

  2011

  Thomas Marsland; Francis Arena; Alan Yeilding; Mike Glodé; Lee Ellis; James Yu; Craig Henderson; Larry Wagman; Steven Piver; Bruce Minsky; et al.

  Perspective on...the new PSA screening recommendations.

  Oncology (Williston Park, N.Y.). 2011;25(12):1183, 1187-1188, 1190.

• 334.

  2011

  David Z. Chang; Ying Ma; Baoan Ji; Huamin Wang; Defeng Deng; Yan Liu; James L. Abbruzzese; Yong-Jun Liu; Craig D. Logsdon; Patrick Hwu

  Mast cells in tumor microenvironment promotes the in vivo growth of pancreatic ductal adenocarcinoma

  Clinical Cancer Research. 2011;17(22):7015-7023.

• 335.

  2011

  Jean-Pierre Gillet; Anna Maria Calcagno; Sudhir Varma; Miguel Marino; Lisa J. Green; Meena I. Vora; Chirayu Patel; Josiah N. Orina; Tatiana A. Eliseeva; Vineet Singal; et al.

  Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance

  Proceedings of the National Academy of Sciences of the United States of America. 2011;108(46):18708-18713.

• 336.

  2011

  Zobeida Cruz-Monserrate; Wael R. Abd-Elgaliel; Tobias Grote; Defeng Deng; Baoan Ji; Thiruvengadam Arumugam; Huamin Wang; Ching-Hsuan Tung; Craig D. Logsdon

  Detection of pancreatic cancer tumours and precursor lesions by cathepsin E activity in mouse models

  Gut. 2011.

• 337.

  2011

  Alpa M. Nick; Rebecca L. Stone; Guillermo Armaiz-Pena; Bulent Ozpolat; Ibrahim Tekedereli; Whitney S. Graybill; Charles N. Landen; Gabriel Villares; Pablo Vivas-Mejia; Justin Bottsford-Miller; et al.

  Silencing of p130Cas in ovarian carcinoma: A novel mechanism for tumor cell death

  Journal of the National Cancer Institute. 2011;103(21):1596-1612.

• 338.

  2011

  Jill E. Larsen; Tina Cascone; David E. Gerber; John V. Heymach; John D. Minna

  Targeted therapies for lung cancer: Clinical experience and novel agents

  Cancer Journal. 2011;17(6):512-527.

• 339.

  2011

  Neil E. Martin; Lorelei A. Mucci; Massimo Loda; Ronald A. DePinho

  Prognostic determinants in prostate cancer

  Cancer Journal. 2011;17(6):429-437.

• 340.

  2011

  Phillip G. Febbo; Marc Ladanyi; Kenneth D. Aldape; Angelo M. De Marzo; M. Elizabeth Hammond; Daniel F. Hayes; A. John Iafrate; R. Kate Kelley; Guido Marcucci; Shuji Ogino; et al.

  NCCN task force report: Evaluating the clinical utility of tumor markers in oncology

  JNCCN Journal of the National Comprehensive Cancer Network. 2011;9(SUPPL. 5):S1-S32.

• 341.

  2011

  Randala Hamdan; Zhichao Zhou; Eugenie S. Kleinerman

  SDF-1α induces PDGF-B expression and the differentiation of bone marrow cells into pericytes

  Molecular Cancer Research. 2011;9(11):1462-1470.

• 342.

  2011

  Robert L Coleman; Linda R Duska; Pedro T Ramirez; John V Heymach; Aparna A Kamat; Susan C Modesitt; Kathleen M Schmeler; Revathy B Iyer; Michael E Garcia; Debbie L Miller; et al.

  Phase 1-2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancer

  The Lancet Oncology. 2011;12(12):1109-1117.

• 343.

  2011

  Susan K. Lutgendorf; Anil K. Sood

  Biobehavioral factors and cancer progression: Physiological pathways and mechanisms

  Psychosomatic Medicine. 2011;73(9):724-730.

• 344.

  2011

  Maya Zigler; Takafumi Kamiya; Emily C. Brantley; Gabriel J. Villares; Menashe Bar-Eli

  PAR-1 and thrombin: The ties that bind the microenvironment to melanoma metastasis

  Cancer Research. 2011;71(21):6561-6566.

• 345.

  2011

  Anne S Tsao; J. Heymach

  Mesothelioma and small cell lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2011;6(11 Suppl 4):S1825-1826.

• 346.

  2011

  Qingqing Ding; Chun-Ju Chang; Xiaoming Xie; Weiya Xia; Jer-Yen Yang; Shao-Chun Wang; Yan Wang; Jiahong Xia; Libo Chen; Changchung Cai; et al.

  APOBEC3G promotes liver metastasis in an orthotopic mouse model of colorectal cancer and predicts human hepatic metastasis

  Journal of Clinical Investigation. 2011;121(11):4526-4536.

• 347.

  2011

  Puja Gaur; Eric L. Sceusi; Shaija Samuel; Ling Xia; Fan Fan; Yunfei Zhou; Jia Lu; Federico Tozzi; Gabriel Lopez-Berestein; Pablo Vivas-Mejia; et al.

  Identification of cancer stem cells in human gastrointestinal carcinoid and neuroendocrine tumors

  Gastroenterology. 2011;141(5):1728-1737.

• 348.

  2011

  Todd D. Prickett; Xiaomu Wei; Isabel Cardenas-Navia; Jamie K. Teer; Jimmy C. Lin; Vijay Walia; Jared Gartner; Jiji Jiang; Praveen F. Cherukuri; Alfredo Molinolo; et al.

  Exon capture analysis of G protein-coupled receptors identifies activating mutations in GRM3 in melanoma

  Nature Genetics. 2011;43(11):1119-1126.

• 349.

  2011

  Joyce T. O'Connell; Hikaru Sugimoto; Vesselina G. Cooke; Brian A. MacDonald; Ankit I. Mehta; Valerie S. LeBleu; Rajan Dewar; Rafael M. Rocha; Ricardo R. Brentani; Murray B. Resnick; et al.

  VEGF-A and Tenascin-C produced by S100A4 ⁺ stromal cells are important for metastatic colonization

  Proceedings of the National Academy of Sciences of the United States of America. 2011;108(38):16002-16007.

• 350.

  2011

  Eun Sung Park; Sun Jin Kim; Seung Wook Kim; Se-Lyun Yoon; Sun-Hee Leem; Sang-Bae Kim; Soo Mi Kim; Yun-Yong Park; Jae-Ho Cheong; Hyun Goo Woo; et al.

  Cross-species hybridization of microarrays for studying tumor transcriptome of brain metastasis

  Proceedings of the National Academy of Sciences of the United States of America. 2011;108(42):17456-17461.

• 351.

  2011

  David J. McConkey

  RAIDDing ER Stress for Oncolytic Viral Therapy

  Cancer Cell. 2011;20(4):416-418.

• 352.

  2011

  Da Yang; Sofia Khan; Yan Sun; Kenneth Hess; Ilya Shmulevich; Anil K. Sood; Wei Zhang

  Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer

  JAMA - Journal of the American Medical Association. 2011;306(14):1557-1565.

• 353.

  2011

  Ya Cao; Ronald A. Depinho; Matthias Ernst; Karen Vousden

  Cancer research: Past, present and future

  Nature Reviews Cancer. 2011;11(10):749-754.

• 354.

  2011

  Sebastian Vaughan; Jermaine I. Coward; Robert C. Bast; Andy Berchuck; Jonathan S. Berek; James D. Brenton; George Coukos; Christopher C. Crum; Ronny Drapkin; Dariush Etemadmoghadam; et al.

  Rethinking ovarian cancer: Recommendations for improving outcomes

  Nature Reviews Cancer. 2011;11(10):719-725.

• 355.

  2011

  Thiruvengadam Arumugam; Craig D. Logsdon

  S100P: A novel therapeutic target for cancer

  Amino Acids. 2011;41(4):893-899.

• 356.

  2011

  Erin R. King; Zhifei Zu; Yvonne T.M. Tsang; Michael T. Deavers; Anais Malpica; Samuel C. Mok; David M. Gershenson; Kwong-Kwok Wong

  The insulin-like growth factor 1 pathway is a potential therapeutic target for low-grade serous ovarian carcinoma

  Gynecologic Oncology. 2011;123(1):13-18.

• 357.

  2011

  Sebastian Gaiser; Jaroslaw Daniluk; Yan Liu; Lilian Tsou; Jun Chu; Woojin Lee; Daniel S. Longnecker; Craig D. Logsdon; Baoan Ji

  Intracellular activation of trypsinogen in transgenic mice induces acute but not chronic pancreatitis

  Gut. 2011;60(10):1379-1388.

• 358.

  2011

  Jennifer L. Clarke; Michele M. Ennis; W. K. Alfred Yung; Susan M. Chang; Patrick Y. Wen; Timothy F. Cloughesy; Lisa M. Deangelis; H. Ian Robins; Frank S. Lieberman; Howard A. Fine; et al.

  Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma?

  Neuro-Oncology. 2011;13(10):1118-1124.

• 359.

  2011

  Amidou N'Diaye; Gary K. Chen; Cameron D. Palmer; Bing Ge; Bamidele Tayo; Rasika A. Mathias; Jingzhong Ding; Michael A. Nalls; Adebowale Adeyemo; Véronique Adoue; et al.

  Identification, replication, and fine-mapping of loci associated with adult height in individuals of African ancestry

  PLoS Genetics. 2011;7(10).

• 360.

  2011

  Angela Criscimanna; Julie A. Speicher; Golbahar Houshmand; Chiyo Shiota; Krishna Prasadan; Baoan Ji; Craig D. Logsdon; George K. Gittes; Farzad Esni

  Duct cells contribute to regeneration of endocrine and acinar cells following pancreatic damage in adult mice

  Gastroenterology. 2011;141(4):1451-1462.e6.

• 361.

  2011

  John V. Heymach; Terry J. Shackleford; Hai T. Tran; Suk-Young Yoo; Kim-Anh Do; Melanie Wergin; Pierre Saintigny; Robin T. Vollmer; Thomas J. Polascik; Denise C. Snyder; et al.

  Effect of low-fat diets on plasma levels of NF-κB-regulated inflammatory cytokines and angiogenic factors in men with prostate cancer

  Cancer Prevention Research. 2011;4(10):1590-1598.

• 362.

  2011

  Koji Matsuo; Michele L. Eno; Edward H. Ahn; Mian M.K. Shahzad; Dwight D. Im; Neil B. Rosenshein; Anil K. Sood

  Multidrug resistance gene (MDR-1) and risk of brain metastasis in epithelial ovarian, fallopian tube, and peritoneal cancer

  American Journal of Clinical Oncology: Cancer Clinical Trials. 2011;34(5):488-493.

• 363.

  2011

  Curtis A. Pettaway; Lois E. Lamerato; Michael T. Eaddy; Jessie K. Edwards; Susan L. Hogue; Martin M. Crane

  Benign prostatic hyperplasia: Racial differences in treatment patterns and prostate cancer prevalence

  BJU International. 2011;108(8):1302-1308.

• 364.

  2011

  Adam J. Bass; Michael S. Lawrence; Lear E. Brace; Alex H. Ramos; Yotam Drier; Kristian Cibulskis; Carrie Sougnez; Douglas Voet; Gordon Saksena; Andrey Sivachenko; et al.

  Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion

  Nature Genetics. 2011;43(10):964-970.

• 365.

  2011

  Hussein A. Abbas; Vinod Pant; Guillermina Lozano

  The ups and downs of p53 regulation in hematopoietic stem cells

  Cell Cycle. 2011;10(19):3257-3262.

• 366.

  2011

  Christopher Lieu; John Heymach; Michael Overman; Hai Tran; Scott Kopetz

  Beyond VEGF: Inhibition of the fibroblast growth factor pathway and antiangiogenesis

  Clinical Cancer Research. 2011;17(19):6130-6139.

• 367.

  2011

  Stephen M. Sykes; Steven W. Lane; Lars Bullinger; Demetrios Kalaitzidis; Rushdia Yusuf; Borja Saez; Francesca Ferraro; Francois Mercier; Harshabad Singh; Kristina M. Brumme; et al.

  Erratum: AKT/FOXO signaling enforces reversible differentiation blockade in myeloid leukemias (Cell (2011) 146 (697-708))

  Cell. 2011;147(1):247.

• 368.

  2011

  Delphine R. Boulbés; Tattym Shaiken; Dos D. Sarbassov

  Endoplasmic reticulum is a main localization site of mTORC2

  Biochemical and Biophysical Research Communications. 2011;413(1):46-52.

• 369.

  2011

  Wei Hu; Chunhua Lu; Hee Dong Han; Jie Huang; De-Yu Shen; Rebecca L. Stone; Alpa M. Nick; Mian M. K. Shahzad; Edna Mora; Nicholas B. Jennings; et al.

  Biological roles of the delta family notch ligand Dll4 in tumor and endothelial cells in ovarian cancer

  Cancer Research. 2011;71(18):6030-6039.

• 370.

  2011

  Stephen M. Sykes; Steven W. Lane; Lars Bullinger; Demetrios Kalaitzidis; Rushdia Yusuf; Borja Saez; Francesca Ferraro; Francois Mercier; Harshabad Singh; Kristina M. Brumme; et al.

  AKT/FOXO signaling enforces reversible differentiation blockade in myeloid leukemias

  Cell. 2011;146(5):697-708.

• 371.

  2011

  Sendurai A. Mani; Michelle Craig Barton

  HDAC3 at the Fulcrum of an Epithelial-Mesenchymal Balance

  Molecular Cell. 2011;43(5):697-698.

• 372.

  2011

  Yang Xie; Guanghua Xiao; Kevin R. Coombes; Carmen Behrens; Luisa M. Solis; Gabriela Raso; Luc Girard; Heidi S. Erickson; Jack Roth; John V. Heymach; et al.

  Robust gene expression signature from formalin-fixed paraffin-embedded samples predicts prognosis of non-small-cell lung cancer patients

  Clinical Cancer Research. 2011;17(17):5705-5714.

• 373.

  2011

  Adam D. Steg; Ashwini A. Katre; Blake Goodman; Hee-Dong Han; Alpa M. Nick; Rebecca L. Stone; Robert L. Coleman; Ronald D. Alvarez; Gabriel Lopez-Berestein; Anil K. Sood; et al.

  Targeting the Notch ligand jagged1 in both tumor cells and stroma in ovarian cancer

  Clinical Cancer Research. 2011;17(17):5674-5685.

• 374.

  2011

  Thomas De Raedt; Zandra Walton; Jessica L. Yecies; Danan Li; Yimei Chen; Clare F. Malone; Ophélia Maertens; Seung Min Jeong; Roderick T. Bronson; Valerie Lebleu; et al.

  Exploiting cancer cell vulnerabilities to develop a combination therapy for ras-driven tumors

  Cancer Cell. 2011;20(3):400-413.

• 375.

  2011

  Michelle D. Williams; Li Zhang; Danielle D. Elliott; Nancy D. Perrier; Guillermina Lozano; Gary L. Clayman; Adel K. El-Naggar

  Differential gene expression profiling of aggressive and nonaggressive follicular carcinomas

  Human Pathology. 2011;42(9):1213-1220.

• 376.

  2011

  Charles M. Balch; Jeffrey E. Gershenwald; Seng-Jaw Soong; John F. Thompson

  Update on the melanoma staging system: The importance of sentinel node staging and primary tumor mitotic rate

  Journal of Surgical Oncology. 2011;104(4):379-385.

• 377.

  2011

  Merrick I. Ross; Jeffrey E. Gershenwald

  Evidence-based treatment of early-stage melanoma

  Journal of Surgical Oncology. 2011;104(4):341-353.

• 378.

  2011

  Filip Janku; David J. McConkey; David S. Hong; Razelle Kurzrock

  Autophagy as a target for anticancer therapy

  Nature Reviews Clinical Oncology. 2011;8(9):528-539.

• 379.

  2011

  Ayumu Taguchi; Katerina Politi; Sharon J. Pitteri; William W. Lockwood; Vitor M. Faça; Karen Kelly-Spratt; Chee-Hong Wong; Qing Zhang; Alice Chin; Kwon-Sik Park; et al.

  Lung cancer signatures in plasma based on proteome profiling of mouse tumor models

  Cancer Cell. 2011;20(3):289-299.

• 380.

  2011

  Robert L. Askew; Richard J. Swartz; Yan Xing; Scott B. Cantor; Merrick I. Ross; Jeffrey E. Gershenwald; J. Lynn Palmer; Jeffrey E. Lee; Janice N. Cormier

  Mapping FACT-melanoma quality-of-life scores to EQ-5D health utility weights

  Value in Health. 2011;14(6):900-906.

• 381.

  2011

  Justina McEvoy; Jacqueline Flores-Otero; Jiakun Zhang; Katie Nemeth; Rachel Brennan; Cori Bradley; Fred Krafcik; Carlos Rodriguez-Galindo; Matthew Wilson; Shunbin Xiong; et al.

  Coexpression of Normally Incompatible Developmental Pathways in Retinoblastoma Genesis

  Cancer Cell. 2011;20(2):260-275.

• 382.

  2011

  Kenneth L. Scott; Cristina Nogueira; Timothy P. Heffernan; Remco van Doorn; Sabin Dhakal; Jason A. Hanna; Chengyin Min; Mariela Jaskelioff; Yonghong Xiao; Chang-Jiun Wu; et al.

  Proinvasion Metastasis Drivers in Early-Stage Melanoma Are Oncogenes

  Cancer Cell. 2011;20(2):277.

• 383.

  2011

  Matthew P. Schlumbrecht; Charlotte C. Sun; Karen N. Wong; Russell R. Broaddus; David M. Gershenson; Diane C. Bodurka

  Clinicodemographic factors influencing outcomes in patients with low-grade serous ovarian carcinoma

  Cancer. 2011;117(16):3741-3749.

• 384.

  2011

  Fei Yang; Ximing Tang; Erick Riquelme; Carmen Behrens; Monique B. Nilsson; Uma Giri; Marileila Varella-Garcia; Lauren A. Byers; Heather Y. Lin; Jing Wang; et al.

  Increased VEGFR-2 gene copy is associated with chemoresistance and shorter survival in patients with non-small-cell lung carcinoma who receive adjuvant chemotherapy

  Cancer Research. 2011;71(16):5512-5521.

• 385.

  2011

  Koji Matsuo; Masato Nishimura; Justin N. Bottsford-Miller; Jie Huang; Kakajan Komurov; Guillermo N. Armaiz-Pena; Mian M. K. Shahzad; Rebecca L. Stone; Ju Won Roh; Angela M. Sanguino; et al.

  Targeting Src in mucinous ovarian carcinoma

  Clinical Cancer Research. 2011;17(16):5367-5378.

• 386.

  2011

  Merrick I. Ross; Jeffrey E. Gershenwald

  The authors reply

  New England Journal of Medicine. 2011;365(6):571.

• 387.

  2011

  Giulio F. Draetta; Ronald A. DePinho

  Cancer drug discovery faces the FACT

  Science Translational Medicine. 2011;3(95).

• 388.

  2011

  Melanie G. Cornejo; Vinciane Mabialah; Stephen M. Sykes; Tulasi Khandan; Cristina Lo Celso; Cécile K. Lopez; Paola Rivera-Muñoz; Philippe Rameau; Zuzana Tothova; Jon C. Aster; et al.

  Crosstalk between NOTCH and AKT signaling during murine megakaryocyte lineage specification

  Blood. 2011;118(5):1264-1273.

• 389.

  2011

  Melissa M. Singh; Christa A. Manton; Krishna P. Bhat; Wen-Wei Tsai; Kenneth Aldape; Michelle C. Barton; Joya Chandra

  Inhibition of LSD1 sensitizes glioblastoma cells to histone deacetylase inhibitors

  Neuro-Oncology. 2011;13(8):894-903.

• 390.

  2011

  Tamara Terzian; Melissa Dumble; Farinaz Arbab; Christina Thaller; Lawrence A. Donehower; Guillermina Lozano; Monica J. Justice; Dennis R Roop; Neil F. Box

  Rpl27a mutation in the sooty foot ataxia mouse phenocopies high p53 mouse models

  Journal of Pathology. 2011;224(4):540-552.

• 391.

  2011

  Maria Angelica Cortez; Carlos Bueso-Ramos; Jana Ferdin; Gabriel Lopez-Berestein; Anil K. Sood; George A. Calin

  MicroRNAs in body fluids-the mix of hormones and biomarkers

  Nature Reviews Clinical Oncology. 2011;8(8):467-477.

• 392.

  2011

  Fabio P.S. Santos; Hagop Kantarjian; David McConkey; Susan O'Brien; Stefan Faderl; Gautam Borthakur; Alessandra Ferrajoli; John Wright; Jorge Cortes

  Pilot study of bortezomib for patients with imatinib-refractory chronic myeloid leukemia in chronic or accelerated phase

  Clinical Lymphoma, Myeloma and Leukemia. 2011;11(4):355-360.

• 393.

  2011

  Katherine Regan Sterba; Richard J. Swartz; Karen Basen-Engquist; Peter C. Black; Curtis A. Pettaway

  Long-term quality of life after radical prostatectomy in wives of men in the postoperative adjuvant androgen deprivation trial

  Supportive Care in Cancer. 2011;19(8):1117-1124.

• 394.

  2011

  Nadezhda V. Koshkina; Krithi Rao-Bindal; Eugenie S. Kleinerman

  Effect of the histone deacetylase inhibitor SNDX-275 on Fas signaling in osteosarcoma cells and the feasibility of its topical application for the treatment of osteosarcoma lung metastases

  Cancer. 2011;117(15):3457-3467.

• 395.

  2011

  Sapna P. Patel; Kevin B. Kim; Nicholas E. Papadopoulos; Wen-Jen Hwu; Patrick Hwu; Victor G. Prieto; Menashe Bar-Eli; Maya Zigler; Andrey Dobroff; Yulia Bronstein; et al.

  A phase II study of gefitinib in patients with metastatic melanoma

  Melanoma Research. 2011;21(4):357-363.

• 396.

  2011

  Damian Medici; Scott Potenta; Raghu Kalluri

  Transforming growth factor-β2 promotes Snail-mediated endothelial - Mesenchymal transition through convergence of Smad-dependent and Smad-independent signalling

  Biochemical Journal. 2011;437(3):515-520.

• 397.

  2011

  Bryan Moon; Patrick Lin; Robert Satcher; Valerae Lewis

  Simultaneous nailing of skeletal metastases: Is the mortality really that high?

  Clinical Orthopaedics and Related Research. 2011;469(8):2367-2370.

• 398.

  2011

  Thiruvengadam Arumugam; Will Brandt; Vijaya Ramachandran; Tood T. Moore; Huamin Wang; Felicity E. May; Bruce R. Westley; Rosa F. Hwang; Craig D. Logsdon

  Trefoil factor 1 stimulates both pancreatic cancer and stellate cells and increases metastasis

  Pancreas. 2011;40(6):815-822.

• 399.

  2011

  Jinyun Chen; Xifeng Wu; Mala Pande; Christopher I. Amos; Ann M. Killary; Subrata Sen; Marsha L. Frazier

  Susceptibility locus for lung cancer at 15q25.1 is not associated with risk of pancreatic cancer

  Pancreas. 2011;40(6):872-875.

• 400.

  2011

  Alexander A. Parikh; Lee M. Ellis

  Circulating angiogenic factors, tumor cells, and outcome after resection of metastatic colorectal cancer-what does it mean?

  Annals of Surgical Oncology. 2011;18(8):2111-2113.

• 401.

  2011

  Elsa R. Flores; Georg Halder

  Stem cell proliferation in the skin: α-catenin takes over the Hippo pathway

  Science Signaling. 2011;4(183).

• 402.

  2011

  F. Morgillo; T. Cascone; E. D'Aiuto; E. Martinelli; T. Troiani; P. Saintigny; R. De Palma; J.V. Heymach; L. Berrino; C. Tuccillo; et al.

  Antitumour efficacy of MEK inhibitors in human lung cancer cells and their derivatives with acquired resistance to different tyrosine kinase inhibitors

  British Journal of Cancer. 2011;105(3):382-392.

• 403.

  2011

  Vinod Pant; Shunbin Xiong; Tomoo Iwakuma; Alfonso Quintaś-Cardama; Guillermina Lozano

  Heterodimerization of Mdm2 and Mdm4 is critical for regulating p53 activity during embryogenesis but dispensable for p53 and Mdm2 stability

  Proceedings of the National Academy of Sciences of the United States of America. 2011;108(29):11995-12000.

• 404.

  2011

  Wen-Tai Chiu; Hsueh-Te Lee; Feng-Ju Huang; Kenneth D. Aldape; Jun Yao; Patricia S. Steeg; Cheng-Yang Chou; Zhimin Lu; Keping Xie; Suyun Huang

  Caveolin-1 upregulation mediates suppression of primary breast tumor growth and brain metastases by Stat3 inhibition

  Cancer Research. 2011;71(14):4932-4943.

• 405.

  2011

  John F. De Groot; Yuji Piao; Hai Tran; Mark Gilbert; Hua-Kang Wu; Jun Liu; B. Nebiyou Bekele; Tim Cloughesy; Minesh Mehta; H. Ian Robins; et al.

  Myeloid biomarkers associated with glioblastoma response to anti-VEGF therapy with aflibercept

  Clinical Cancer Research. 2011;17(14):4872-4881.

• 406.

  2011

  Richard W. Joseph; Vijay R. Peddareddigari; Ping Liu; Priscilla W. Miller; Willem W. Overwijk; Nebiyou B. Bekele; Merrick I. Ross; Jeffrey E. Lee; Jeffrey E. Gershenwald; Anthony Lucci; et al.

  Impact of clinical and pathologic features on tumor-infiltrating lymphocyte expansion from surgically excised melanoma metastases for adoptive T-cell therapy

  Clinical Cancer Research. 2011;17(14):4882-4891.

• 407.

  2011

  Ergün Sahin; Simona Colla; Marc Liesa; Javid Moslehi; Florian L. Müller; Mira Guo; Marcus Cooper; Darrell Kotton; Attila J. Fabian; Carl Walkey; et al.

  Erratum: Telomere dysfunction induces metabolic and mitochondrial compromise (Nature (2011) 470 (359-365))

  Nature. 2011;475(7355):254.

• 408.

  2011

  Kenneth L. Scott; Cristina Nogueira; Timothy P. Heffernan; Remco van Doorn; Sabin Dhakal; Jason A. Hanna; Chengyin Min; Mariela Jaskelioff; Yonghong Xiao; Chang-Jiun Wu; et al.

  Proinvasion Metastasis Drivers in Early-Stage Melanoma Are Oncogenes

  Cancer Cell. 2011;20(1):92-103.

• 409.

  2011

  Javier E. Girardini; Marco Napoli; Silvano Piazza; Alessandra Rustighi; Carolina Marotta; Enrico Radaelli; Valeria Capaci; Lee Jordan; Phil Quinlan; Alastair Thompson; et al.

  A Pin1/Mutant p53 Axis Promotes Aggressiveness in Breast Cancer

  Cancer Cell. 2011;20(1):79-91.

• 410.

  2011

  David M. Gershenson

  The future of gynecologic oncology: Are we headed for super-specialization?

  Gynecologic Oncology. 2011;122(1):3-4.

• 411.

  2011

  Seung Wook Kim; Jang Seong Kim; John Papadopoulos; Hyun Jin Choi; Junqin He; Marva Maya; Robert R. Langley; Dominic Fan; Isaiah J. Fidler; Sun-Jin Kim

  Consistent interactions between tumor cell IL-6 and macrophage TNF-α enhance the growth of human prostate cancer cells in the bone of nude mouse

  International Immunopharmacology. 2011;11(7):859-869.

• 412.

  2011

  John F. De Groot; Kathleen R. Lamborn; Susan M. Chang; Mark R. Gilbert; Timothy F. Cloughesy; Kenneth Aldape; Jun Yao; Edward F. Jackson; Frank Lieberman; H. Ian Robins; et al.

  Phase II study of aflibercept in recurrent malignant glioma: A North American brain tumor consortium study

  Journal of Clinical Oncology. 2011;29(19):2689-2695.

• 413.

  2011

  Amal Melhem-Bertrandt; Mariana Chavez-MacGregor; Xiudong Lei; Erika N. Brown; Richard T. Lee; Funda Meric-Bernstam; Anil K. Sood; Suzanne D. Conzen; Gabriel N. Hortobagyi; Ana-Maria Gonzalez-Angulo

  Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer

  Journal of Clinical Oncology. 2011;29(19):2645-2652.

• 414.

  2011

  Amalia M. DeComas; Michael T. Deavers; A. Kevin Raymond; John E. Madewell; Valerae O. Lewis

  Intraneural parachordoma of the arm with regional metastases

  Skeletal Radiology. 2011;40(7):943-946.

• 415.

  2011

  Dongmin Gu; Nam Ky Tonthat; Moonsup Lee; Hong Ji; Krishna P. Bhat; Faith Hollingsworth; Kenneth D. Aldape; Maria A. Schumacher; Thomas P. Zwaka; Pierre D. McCrea

  Caspase-3 cleavage links δ-catenin to the novel nuclear protein ZIFCAT

  Journal of Biological Chemistry. 2011;286(26):23178-23188.

• 416.

  2011

  Yoshitsugu Mitani; Jie Li; Randal S. Weber; Scott L. Lippman; Elsa R. Flores; Carlos Caulin; Adel K. El-Naggar

  Expression and regulation of the Δn and TAp63 isoforms in salivary gland tumorigenesis: Clinical and experimental findings

  American Journal of Pathology. 2011;179(1):391-399.

• 417.

  2011

  Vinod Ravi; Wei-Lien Wang; Valerae O. Lewis

  Treatment of tenosynovial giant cell tumor and pigmented villonodular synovitis

  Current Opinion in Oncology. 2011;23(4):361-366.

• 418.

  2011

  Paul K. Hegarty; Jane Suh; Mark B. Fisher; Jennifer Taylor; Tri H. Nguyen; Doina Ivan; Victor G. Prieto; Lance C. Pagliaro; Curtis A. Pettaway

  Penoscrotal extramammary Paget's disease: The University of Texas M. D. Anderson Cancer Center contemporary experience

  Journal of Urology. 2011;186(1):97-102.

• 419.

  2011

  Yan Sun; Kenji Yokoi; Hui Li; Jun Gao; Limei Hu; Ben Liu; Kexin Chen; Stanley R. Hamilton; Dominic Fan; Baocun Sun; et al.

  NGAL expression is elevated in both colorectal adenoma-carcinoma sequence and cancer progression and enhances tumorigenesis in xenograft mouse models

  Clinical Cancer Research. 2011;17(13):4331-4340.

• 420.

  2011

  D. Bell; A. Berchuck; M. Birrer; J. Chien; D.W. Cramer; F. Dao; R. Dhir; P. Disaia; H. Gabra; P. Glenn; et al.

  Integrated genomic analyses of ovarian carcinoma

  Nature. 2011;474(7353):609-615.

• 421.

  2011

  R.S. Bhatt; A.J. Zurita; A. O'Neill; A. Norden-Zfoni; L. Zhang; H.K. Wu; P.Y. Wen; D. George; V.P. Sukhatme; M.B. Atkins; et al.

  Increased mobilisation of circulating endothelial progenitors in von Hippel-Lindau disease and renal cell carcinoma

  British Journal of Cancer. 2011;105(1):112-117.

• 422.

  2011

  Vassiliki Tzelepi; Eleni Efstathiou; Sijin Wen; Patricia Troncoso; Maria Karlou; Curtis A. Pettaway; Louis L. Pisters; Anh Hoang; Christopher J. Logothetis; Lance C. Pagliaro

  Persistent, biologically meaningful prostate cancer after 1 year of androgen ablation and docetaxel treatment

  Journal of Clinical Oncology. 2011;29(18):2574-2581.

• 423.

  2011

  Winston W. Huh; B. Ashleigh Guadagnolo; Mark F. Munsell; Shreyaskumar Patel; Valerae O. Lewis

  Soft tissue sarcomas of the popliteal fossa

  Cancer. 2011;117(12):2728-2734.

• 424.

  2011

  Liang Xie; Michael B. Duncan; Jessica Pahler; Hikaru Sugimoto; Margot Martino; Julie Lively; Thomas Mundel; Mary Soubasakos; Kristofer Rubin; Takaaki Takeda; et al.

  Counterbalancing angiogenic regulatory factors control the rate of cancer progression and survival in a stage-specific manner

  Proceedings of the National Academy of Sciences of the United States of America. 2011;108(24):9939-9944.

• 425.

  2011

  Francisco Ayala De La Peña; Keizo Kanasaki; Megumi Kanasaki; Neelima Tangirala; Genta Maeda; Raghu Kalluri

  Loss of p53 and acquisition of angiogenic microRNA profile are insufficient to facilitate progression of bladder urothelial carcinoma in situ to invasive carcinoma

  Journal of Biological Chemistry. 2011;286(23):20778-20787.

• 426.

  2011

  Joyce C. Tse; Raghu Kalluri

  Waking up dormant tumors

  Breast Cancer Research. 2011;13(3).

• 427.

  2011

  Ana M. Gonzalez-Angulo; Gabriel N. Hortobagyi; Lee M. Ellis

  Targeted therapies: Peaking beneath the surface of recent bevacizumab trials

  Nature Reviews Clinical Oncology. 2011;8(6):319-320.

• 428.

  2011

  Edward S. Kim; Roy S. Herbst; Ignacio I. Wistuba; J. Jack Lee; George R. Blumenschein Jr.; Anne Tsao; David J. Stewart; Marshall E. Hicks; Jeremy Erasmus Jr.; Sanjay Gupta; et al.

  The BATTLE trial: Personalizing Therapy for Lung Cancer

  Cancer Discovery. 2011;1(1):44-53.

• 429.

  2011

  Myrthala Moreno-Smith; Chunhua Lu; Mian M. K. Shahzad; Guillermo N. Armaiz Pena; Julie K. Allen; Rebecca L. Stone; Lingegowda S. Mangala; Hee Dong Han; Hye Sun Kim; Donna Farley; et al.

  Dopamine blocks stress-mediated ovarian carcinoma growth

  Clinical Cancer Research. 2011;17(11):3649-3659.

• 430.

  2011

  Pablo E. Vivas-Mejia; Cristian Rodriguez-Aguayo; Hee-Dong Han; Mian M. K. Shahzad; Fatma Valiyeva; Mineko Shibayama; Arturo Chavez-Reyes; Anil K. Sood; Gabriel Lopez-Berestein

  Silencing survivin splice variant 2B leads to antitumor activity in taxane-resistant ovarian cancer

  Clinical Cancer Research. 2011;17(11):3716-3726.

• 431.

  2011

  John F. Thompson; Seng-Jaw Soong; Charles M. Balch; Jeffrey E. Gershenwald; Shouluan Ding; Daniel G. Coit; Keith T. Flaherty; Phyllis A. Gimotty; Timothy Johnson; Marcella M. Johnson; et al.

  Prognostic significance of mitotic rate in localized primary cutaneous melanoma: An analysis of patients in the multi-institutional american joint committee on cancer melanoma staging database

  Journal of Clinical Oncology. 2011;29(16):2199-2205.

• 432.

  2011

  Erin R. King; Celestine S. Tung; Yvonne T.M. Tsang; Zhifei Zu; Gabriel T.M. Lok; Michael T. Deavers; Anais Malpica; Judith K. Wolf; Karen H. Lu; Michael J. Birrer; et al.

  The anterior gradient homolog 3 (AGR3) gene is associated with differentiation and survival in ovarian cancer

  American Journal of Surgical Pathology. 2011;35(6):904-912.

• 433.

  2011

  Stacey Moore-Olufemi; Cynthia Herzog; Carla Warneke; Jerry E. Gershenwald; Paul Mansfield; Merrick Ross; Victor Prieto; Kevin P. Lally; Andrea Hayes-Jordan

  Outcomes in pediatric melanoma: Comparing prepubertal to adolescent pediatric patients

  Annals of Surgery. 2011;253(6):1211-1215.

• 434.

  2011

  Kathleen M. Schmeler; Charlotte C. Sun; Anais Malpica; Michael T. Deavers; Diane C. Bodurka; David M. Gershenson

  Low-grade serous primary peritoneal carcinoma

  Gynecologic Oncology. 2011;121(3):482-486.

• 435.

  2011

  Lauren J. Akers; Wendy Fang; Alejandro G. Levy; Anna R. Franklin; Peng Huang; Patrick A. Zweidler-McKay

  Targeting glycolysis in leukemia: A novel inhibitor 3-BrOP in combination with rapamycin

  Leukemia Research. 2011;35(6):814-820.

• 436.

  2011

  Andrew B. Lassman; Fabio M. Iwamoto; Timothy F. Cloughesy; Kenneth D. Aldape; Andreana L. Rivera; April F. Eichler; David N. Louis; Nina A. Paleologos; Barbara J. Fisher; Lynn S. Ashby; et al.

  International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors

  Neuro-Oncology. 2011;13(6):649-659.

• 437.

  2011

  Zhimin Tong; Subhankar Chakraborty; Bokyung Sung; Pooja Koolwal; Sukhwinder Kaur; Bharat B. Aggarwal; Sendurai A. Mani; Robert S. Bresalier; Surinder K. Batra; Sushovan Guha

  Epidermal growth factor down-regulates the expression of neutrophil gelatinase-associated lipocalin (NGAL) through E-cadherin in pancreatic cancer cells

  Cancer. 2011;117(11):2408-2418.

• 438.

  2011

  Chih-Chieh Wu; Ralf Krahe; Guillermina Lozano; Baili Zhang; Charmaine D. Wilson; Eun-Ji Jo; Christopher I. Amos; Sanjay Shete; Louise C. Strong

  Joint effects of germ-line TP53 mutation, MDM2 SNP309, and gender on cancer risk in family studies of Li-Fraumeni syndrome

  Human Genetics. 2011;129(6):663-673.

• 439.

  2011

  Peter J. Frederick; Pedro T. Ramirez; Lacey McQuinn; Michael R. Milam; Diane M. Weber; Robert L. Coleman; David M. Gershenson; Charles N. Landen

  Preoperative factors predicting survival after secondary cytoreduction for recurrent ovarian cancer

  International Journal of Gynecological Cancer. 2011;21(5):831-836.

• 440.

  2011

  J. Milburn Jessup; Leonard L. Gunderson; Frederick L. Greene; Mary Kay Washington; Carolyn C. Compton; Leslie H. Sobin; Bruce Minsky; Richard M. Goldberg; Stanley R. Hamilton

  2010 staging system for colon and rectal carcinoma

  Annals of Surgical Oncology. 2011;18(6):1513-1517.

• 441.

  2011

  Yunming Ying; Pradip Ghosh; Liwei Guo; Ashutosh Pal; Uday Mukhapadhyay; Zhenghong Peng; Hsin Hsien Yeh; Susanna Bertolini; Leo Garcia Flores; Daniel Young; et al.

  Synthesis and ex vivo autoradiographic evaluation of ethyl-β-d- galactopyranosyl-(1,4′)-2′-deoxy-2′-[¹⁸F]fluoro- β-d-glucopyranoside-a novel radioligand for lactose-binding protein: Implications for early detection of pancreatic carcinomas with PET

  Molecular Imaging and Biology. 2011;13(3):536-546.

• 442.

  2011

  Deborah J. Del Junco; Erin E. Fox; Sharon Cooper; Marc Goldhagen; Erik Koda; David Rogers; Edith Canby-Hagino; Jeri Kim; Curtis Pettaway; Douglas D. Boyd

  Increasing low risk prostate cancer incidence in United States Air Force servicemen and selection of treatments

  Journal of Urology. 2011;185(6):2137-2142.

• 443.

  2011

  Haoqiang Ying; Kutlu G. Elpek; Anant Vinjamoori; Stephanie M. Zimmerman; Gerald C. Chu; Haiyan Yan; Eliot Fletcher-Sananikone; Hailei Zhang; Yingchun Liu; Wei Wang; et al.

  PTEN is a major tumor suppressor in pancreatic ductal adenocarcinoma and regulates an NF-κB-cytokine network

  Cancer Discovery. 2011;1(2):158-169.

• 444.

  2011

  Menashe Bar-Eli

  Searching for the melano-miRs: MiR-214 drives melanoma metastasis

  EMBO Journal. 2011;30(10):1880-1881.

• 445.

  2011

  Filip Janku; David J. McConkey; David S. Hong; Razelle Kurzrock

  Autophagy as a target for anticancer therapy

  Nature Reviews Clinical Oncology. 2011.

• 446.

  2011

  Maya Zigler; Gabriel J. Villares; Andrey S. Dobroff; Hua Wang; Li Huang; Russell R. Braeuer; Takafumi Kamiya; Vladislava O. Melnikova; Renduo Song; Ran Friedman; et al.

  Expression of Id-1 is regulated by MCAM/MUC18: A missing link in melanoma progression

  Cancer Research. 2011;71(10):3494-3504.

• 447.

  2011

  Jeffrey E. Gershenwald; Merrick I. Ross

  Sentinel-lymph-node biopsy for cutaneous melanoma

  New England Journal of Medicine. 2011;364(18):1738-1745.

• 448.

  2011

  Robin A. Lacour; Shannon N. Westin; Larissa A. Meyer; Shana N. Wingo; John O. Schorge; Rebecca Brooks; David Mutch; Ashley Molina; Rebecca Sutphen; MacK Barnes; et al.

  Improved survival in non-Ashkenazi Jewish ovarian cancer patients with BRCA1 and BRCA2 gene mutations

  Gynecologic Oncology. 2011;121(2):358-363.

• 449.

  2011

  Jay B. Shah; David J. McConkey; Colin P.N. Dinney

  New strategies in muscle-invasive bladder cancer: On the road to personalized medicine

  Clinical Cancer Research. 2011;17(9):2608-2612.

• 450.

  2011

  Hee Dong Han; Edna M. Mora; Ju Won Roh; Masato Nishimura; Sun Joo Lee; Rebecca L. Stone; Menashe Bar-Eli; Gabriel Lopez-Berestein; Anil K. Sood

  Chitosan hydrogel for localized gene silencing

  Cancer Biology and Therapy. 2011;11(9):839-845.

• 451.

  2011

  Edmund Chiong; I.-Ling Lee; Ali Dadbin; Anita L. Sabichi; Loleta Harris; Diana Urbauer; David J. McConkey; Rian J. Dickstein; Tiewei Cheng; H. Barton Grossman

  Effects of mTOR inhibitor everolimus (RAD001) on bladder cancer cells

  Clinical Cancer Research. 2011;17(9):2863-2873.

• 452.

  2011

  Terri S. Armstrong; Sujit Prabhu; Kenneth Aldape; Betsy Hossan; Sanghee Kang; Amanda Childress; Lori Tolentino; Mark R. Gilbert

  A case of soft tissue metastasis from glioblastoma and review of the literature

  Journal of Neuro-Oncology. 2011;103(1):167-172.

• 453.

  2011

  Zhichao Zhou; Keri Schadler Stewart; Ling Yu; Eugenie S. Kleinerman

  Bone marrow cells participate in tumor vessel formation that supports the growth of Ewing's sarcoma in the lung

  Angiogenesis. 2011;14(2):125-133.

• 454.

  2011

  Xiaomu Wei; Vijay Walia; Jimmy C. Lin; Jamie K. Teer; Todd D. Prickett; Jared Gartner; Sean Davis; Katherine Stemke-Hale; Michael A. Davies; Jeffrey E. Gershenwald; et al.

  Exome sequencing identifies GRIN2A as frequently mutated in melanoma

  Nature Genetics. 2011;43(5):442-448.

• 455.

  2011

  Stanley P.L. Leong; Jeffrey E. Gershenwald; Seng-Jaw Soong; Dirk Schadendorf; Ahmad A. Tarhini; Sanjiv Agarwala; Axel Hauschild; Christopher W.M. Soon; Adil Daud; Mohammed Kashani-Sabet

  Cutaneous melanoma: A model to study cancer metastasis

  Journal of Surgical Oncology. 2011;103(6):538-549.

• 456.

  2011

  Jonathan A. Ledermann; Christian Marth; Mark S. Carey; Michael Birrer; David D.L. Bowtell; Stan Kaye; Iain McNeish; Amit Oza; Giovanni Scambia; Gordon Rustin; et al.

  Role of molecular agents and targeted therapy in clinical trials for women with ovarian cancer

  International Journal of Gynecological Cancer. 2011;21(4):763-770.

• 457.

  2011

  Isaiah G. Schauer; Anil K. Sood; Samuel Mok; Jinsong Liu

  Cancer-associated fibroblasts and their putative role in potentiating the initiation and development of epithelial ovarian cancer

  Neoplasia. 2011;13(5):393-405.

• 458.

  2011

  Jason S. Lee; Héctor L. Rodríguez-Luccioni; Janet Méndez; Anil K. Sood; Gabriel Lpez-Berestein; Carlos Rinaldi; Madeline Torres-Lugo

  Hyperthermia induced by magnetic nanoparticles improves the effectiveness of the anticancer drug cis-Diamminedichloroplatinum

  Journal of Nanoscience and Nanotechnology. 2011;11(5):4153-4157.

• 459.

  2011

  Marlys H. Witte; Michael T. Dellinger; Donald M. McDonald; S. David Nathanson; Francesco M. Boccardo; Corradino C.C. Campisi; Jonathan P. Sleeman; Jeffrey E. Gershenwald

  Lymphangiogenesis and hemangiogenesis: Potential targets for therapy

  Journal of Surgical Oncology. 2011;103(6):489-500.

• 460.

  2011

  Yingqi Teng; Keizo Kanasaki; Nabeel Bardeesy; Hikaru Sugimoto; Raghu Kalluri

  Deletion of Smad4 in fibroblasts leads to defective chondrocyte maturation and cartilage production in a TGFβ type II receptor independent manner

  Biochemical and Biophysical Research Communications. 2011;407(4):633-639.

• 461.

  2011

  Rongya Tao; Dan Wei; Hanlin Gao; Yunlong Liu; Ronald A. Depinho; X. Charlie Dong

  Hepatic FoxOs regulate lipid metabolism via modulation of expression of the nicotinamide phosphoribosyltransferase gene

  Journal of Biological Chemistry. 2011;286(16):14681-14690.

• 462.

  2011

  Dimple Chakravarty; Sudipa Saha Roy; Challa Ram Babu; Rajasekhar Dandamudi; Tyler J. Curiel; Pablo Vivas-Mejia; Gabriel Lopez-Berestein; Anil K. Sood; Ratna K. Vadlamudi

  Therapeutic targeting of PELP1 prevents ovarian cancer growth and metastasis

  Clinical Cancer Research. 2011;17(8):2250-2259.

• 463.

  2011

  Xiaomu Wei; Vijay Walia; Jimmy C Lin; Jamie K Teer; Todd D Prickett; Jared Gartner; Sean Davis; Katherine Stemke-Hale; Michael A Davies; et al.

  Exome sequencing identifies GRIN2A as frequently mutated in melanoma

  Nature Genetics. 2011.

• 464.

  2011

  Siqing Fu; Wei Hu; Revathy Iyer; John J. Kavanagh; Robert L. Coleman; Charles F. Levenback; Anil K. Sood; Judith K. Wolf; David M. Gershenson; Maurie Markman; et al.

  Phase 1b-2a study to reverse platinum resistance through use of a hypomethylating agent, azacitidine, in patients with platinum-resistant or platinum-refractory epithelial ovarian cancer

  Cancer. 2011;117(8):1661-1669.

• 465.

  2011

  F. Fan; S. Samuel; P. Gaur; J. Lu; N.A. Dallas; L. Xia; D. Bose; V. Ramachandran; L.M. Ellis

  Chronic exposure of colorectal cancer cells to bevacizumab promotes compensatory pathways that mediate tumour cell migration

  British Journal of Cancer. 2011;104(8):1270-1277.

• 466.

  2011

  Sameer Agnihotri; Amparo Wolf; Diana M. Munoz; Christopher J. Smith; Aaron Gajadhar; Andres Restrepo; Ian D. Clarke; Gregory N. Fuller; Santosh Kesari; Peter B. Dirks; et al.

  A GATA4-regulated tumor suppressor network represses formation of malignant human astrocytomas

  Journal of Experimental Medicine. 2011;208(4):689-702.

• 467.

  2011

  Jennifer K. Burzawa; Kathleen M. Schmeler; Pamela T. Soliman; Larissa A. Meyer; Michael W. Bevers; Terri L. Pustilnik; Matthew L. Anderson; Lois M. Ramondetta; Guillermo Tortolero-Luna; Diana L. Urbauer; et al.

  Prospective evaluation of insulin resistance among endometrial cancer patients

  American Journal of Obstetrics and Gynecology. 2011;204(4):355.e1-355.e7.

• 468.

  2011

  Benjamin J. Moeller; John S. Yordy; Michelle D. Williams; Uma Giri; Uma Raju; David P. Molkentine; Lauren A. Byers; John V. Heymach; Michael D. Story; J. Jack Lee; et al.

  DNA repair biomarker profiling of head and neck cancer: Ku80 expression predicts locoregional failure and death following radiotherapy

  Clinical Cancer Research. 2011;17(7):2035-2043.

• 469.

  2011

  Tina Cascone; Matthew H. Herynk; Li Xu; Zhiqiang Du; Humam Kadara; Monique B. Nilsson; Carol J. Oborn; Yun-Yong Park; Baruch Erez; Jörg J. Jacoby; et al.

  Upregulated stromal EGFR and vascular remodeling in mouse xenograft models of angiogenesis inhibitor-resistant human lung adenocarcinoma

  Journal of Clinical Investigation. 2011;121(4):1313-1328.

• 470.

  2011

  Daisuke Sano; Fumihiko Matsumoto; David R. Valdecanas; Mei Zhao; David P. Molkentine; Yoko Takahashi; Ehab Y. Hanna; Vali Papadimitrakopoulou; John Heymach; Luka Milas; et al.

  Vandetanib restores head and neck squamous cell carcinoma cells' sensitivity to cisplatin and radiation In Vivo and In Vitro

  Clinical Cancer Research. 2011;17(7):1815-1827.

• 471.

  2011

  Hye-Sun Kim; Hee Dong Han; Guillermo N. Armaiz-Pena; Rebecca L. Stone; Eun Ji Nam; Jeong-Won Lee; Mian M. K. Shahzad; Alpa M. Nick; Sun Joo Lee; Ju-Won Roh; et al.

  Functional roles of Src and Fgr in ovarian carcinoma

  Clinical Cancer Research. 2011;17(7):1713-1721.

• 472.

  2011

  Kenji Yokoi; David Hawke; Carol J. Oborn; Jin-Young Jang; Yasuhiko Nishioka; Dominic Fan; Seung Wook Kim; Sun-Jin Kim; Isaiah J. Fidler

  Identification and validation of Src and Phospho-Src family proteins in circulating mononuclear cells as novel biomarkers for pancreatic cancer

  Translational Oncology. 2011;4(2):83-91.

• 473.

  2011

  David Cogdell; Woonbok Chung; Yuexin Liu; J Matthew McDonald; Kenneth Aldape; Jean-Pierre J Issa; Gregory N Fuller; Wei Zhang

  Tumor-associated methylation of the putative tumor suppressor AJAP1 gene and association between decreased AJAP1 expression and shorter survival in patients with glioma.

  Chinese journal of cancer. 2011;30(4):247-253.

• 474.

  2011

  Jin-Hyung Ahn; Ho-Jeong Lee; Eun-Kyoung Lee; Hyun-Kyung Yu; Tae-Ho Lee; Yeup Yoon; Sun-Jin Kim; Jang-Seong Kim

  Antiangiogenic kringles derived from human plasminogen and apolipoprotein(a) inhibit fibrinolysis through a mechanism that requires a functional lysine-binding site

  Biological Chemistry. 2011;392(4):347-356.

• 475.

  2011

  John F. De Groot; Erik P. Sulman; Kenneth D. Aldape

  Multigene sets for clinical application in glioma

  JNCCN Journal of the National Comprehensive Cancer Network. 2011;9(4):449-457.

• 476.

  2011

  Jesse C. Selber; Christen Treadway; Adriana Lopez; Valerae O. Lewis; David W. Chang

  The use of free flap for limb salvage in children with tumors of the extremities

  Journal of Pediatric Surgery. 2011;46(4):736-744.

• 477.

  2011

  Lorenzo Cohen; Patricia A. Parker; Luis Vence; Cheryln Savary; Diane Kentor; Curtis Pettaway; Richard Babaian; Louis Pisters; Brian Miles; Qi Wei; et al.

  Presurgical stress management improves postoperative immune function in men with prostate cancer undergoing radical prostatectomy

  Psychosomatic Medicine. 2011;73(3):218-225.

• 478.

  2011

  Chamutal Bornstein; Ran Brosh; Alina Molchadsky; Shalom Madar; Ira Kogan-Sakin; Ido Goldstein; Deepavali Chakravarti; Elsa R. Flores; Naomi Goldfinger; Rachel Sarig; et al.

  SPATA18, a spermatogenesis-associated gene, is a novel transcriptional target of p53 and p63

  Molecular and Cellular Biology. 2011;31(8):1679-1689.

• 479.

  2011

  Anil K. Sood; Susan K. Lutgendorf

  Stress influences on anoikis

  Cancer Prevention Research. 2011;4(4):481-485.

• 480.

  2011

  Russell R. Braeuer; Maya Zigler; Gabriel J. Villares; Andrey S. Dobroff; Menashe Bar-Eli

  Transcriptional control of melanoma metastasis: The importance of the tumor microenvironment

  Seminars in Cancer Biology. 2011;21(2):83-88.

• 481.

  2011

  Mian M.K. Shahzad; Lingegowda S. Mangala; Hee Dong Han; Chunhua Lu; Justin Bottsford-Miller; Masato Nishimura; Edna M. Mora; Jeong-Won Lee; Rebecca L. Stone; Chad V. Pecot; et al.

  Targeted delivery of small interfering RNA using reconstituted high-density lipoprotein nanoparticles

  Neoplasia. 2011;13(4):309-319.

• 482.

  2011

  Damian Medici; Eileen M. Shore; Vitali Y. Lounev; Frederick S. Kaplan; Raghu Kalluri; Bjorn R. Olsen

  Erratum: Conversion of vascular endothelial cells into multipotent stem-like cells (Nature Medicine (2010) 16 (1400-1406))

  Nature Medicine. 2011;17(4):514.

• 483.

  2011

  Peter E. Zage; Timothy C. Graham; Lizhi Zeng; Wendy Fang; Christine Pien; Ken Thress; Charles Omer; Jeffrey L. Brown; Patrick A. Zweidler -Mckay

  The selective Trk inhibitor AZ623 inhibits brain-derived neurotrophic factor-mediated neuroblastoma cell proliferation and signaling and is synergistic with topotecan

  Cancer. 2011;117(6):1321-1329.

• 484.

  2011

  Sonia Melo; Alberto Villanueva; Catia Moutinho; Veronica Davalos; Riccardo Spizzo; Cristina Ivan; Simona Rossi; Fernando Setien; Oriol Casanovas; Laia Simo-Riudalbas; et al.

  Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing

  Proceedings of the National Academy of Sciences of the United States of America. 2011;108(11):4394-4399.

• 485.

  2011

  Sankaranarayanan Kannan; Wendy Fang; Guangchun Song; Charles G. Mullighan; Richard Hammitt; John McMurray; Patrick A. Zweidler-McKay

  Notch/HES1-mediated PARP1 activation: A cell type-specific mechanism for tumor suppression

  Blood. 2011;117(10):2891-2900.

• 486.

  2011

  S. Samuel; F. Fan; L.H. Dang; L. Xia; P. Gaur; L.M. Ellis

  Intracrine vascular endothelial growth factor signaling in survival and chemoresistance of human colorectal cancer cells

  Oncogene. 2011;30(10):1205-1212.

• 487.

  2011

  Arunima Sengupta; Jeffery D. Molkentin; Ji-Hye Paik; Ronald A. DePinho; Katherine E. Yutzey

  FoxO transcription factors promote cardiomyocyte survival upon induction of oxidative stress

  Journal of Biological Chemistry. 2011;286(9):7468-7478.

• 488.

  2011

  Hiroyuki Inuzuka; Shavali Shaik; Ichiro Onoyama; Daming Gao; Alan Tseng; Richard S. Maser; Bo Zhai; Lixin Wan; Alejandro Gutierrez; Alan W. Lau; et al.

  SCF^FBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction

  Nature. 2011;471(7336):104-109.

• 489.

  2011

  Wael Hassaneen; Nicholas B. Levine; Dima Suki; Abhijit L. Salaskar; Alessandra De Moura Lima; Ian E. McCutcheon; Sujit S. Prabh; Frederick F. Lang; Franco DeMonte; Ganesh Rao; et al.

  Multiple craniotomies in the management of multifocal and multicentric glioblastoma

  Journal of Neurosurgery. 2011;114(3):576-584.

• 490.

  2011

  John H. Sampson; Kenneth D. Aldape; Gary E. Archer; April Coan; Annick Desjardins; Allan H. Friedman; Henry S. Friedman; Mark R. Gilbert; James E. Herndon; Roger E. McLendon; et al.

  Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma

  Neuro-Oncology. 2011;13(3):324-333.

• 491.

  2011

  Wenwen Jia; Shuwen Wang; James W. Horner; Ning Wang; Huayan Wang; Edward J. Gunther; Ronald A. De Pinho; Jiyue Zhu

  A BAC transgenic reporter recapitulates in vivo regulation of human telomerase reverse transcriptase in development and tumorigenesis

  FASEB Journal. 2011;25(3):979-989.

• 492.

  2011

  Melinda S. Yates; Larissa A. Meyer; Michael T. Deavers; Molly S. Daniels; Elizabeth R. Keeler; Samuel C. Mok; David M. Gershenson; Karen H. Lu

  Microscopic and early-stage ovarian cancers in brca1/2 mutation carriers: Building a model for early BRCA-associated tumorigenesis

  Cancer Prevention Research. 2011;4(3):463-470.

• 493.

  2011

  A. Samanta; B. Perazzona; S. Chakraborty; X. Sun; H. Modi; R. Bhatia; W. Priebe; R. Arlinghaus

  Janus kinase 2 regulates Bcr-Abl signaling in chronic myeloid leukemia

  Leukemia. 2011;25(3):463-472.

• 494.

  2011

  Matthew H. Kulke; Lillian L. Siu; Joel E. Tepper; George Fisher; Deborah Jaffe; Daniel G. Haller; Lee M. Ellis; Jacqueline K. Benedetti; Emily K. Bergsland; Timothy J. Hobday; et al.

  Future directions in the treatment of neuroendocrine tumors: Consensus report of the National Cancer Institute Neuroendocrine Tumor Clinical Trials Planning Meeting

  Journal of Clinical Oncology. 2011;29(7):934-943.

• 495.

  2011

  Sun-Jin Kim; Jang-Seong Kim; Eun Sung Park; Ju-Seog Lee; Qingtang Lin; Robert R. Langley; Marva Maya; Junqin He; Seung-Wook Kim; Zhang Weihua; et al.

  Astrocytes upregulate survival genes in tumor cells and induce protection from chemotherapy

  Neoplasia. 2011;13(3):286-298.

• 496.

  2011

  Ruiying Zhao; Sai-Ching J. Yeung; Jian Chen; Tomoo Iwakuma; Chun-Hui Su; Bo Chen; Changju Qu; Fanmao Zhang; You-Tzung Chen; Yu-Li Lin; et al.

  Subunit 6 of the COP9 signalosome promotes tumorigenesis in mice through stabilization of MDM2 and is upregulated in human cancers

  Journal of Clinical Investigation. 2011;121(3):851-865.

• 497.

  2011

  Yongxing Wang; Young-Ah Suh; Maren Y. Fuller; James G. Jackson; Shunbin Xiong; Tamara Terzian; Alfonso Quintás-Cardama; James A. Bankson; Adel K. El-Naggar; Guillermina Lozano

  Restoring expression of wild-type p53 suppresses tumor growth but does not cause tumor regression in mice with a p53 missense mutation

  Journal of Clinical Investigation. 2011;121(3):893-904.

• 498.

  2011

  M. Patnana; Y. Bronstein; J. Szklaruk; D.G. Bedi; W.-J. Hwu; J.E. Gershenwald; V.G. Prieto; C.S. Ng

  Multimethod imaging, staging, and spectrum of manifestations of metastatic melanoma

  Clinical Radiology. 2011;66(3):224-236.

• 499.

  2011

  Donald M. Lamkin; Susan K. Lutgendorf; David Lubaroff; Anil K. Sood; Terry G. Beltz; Alan Kim Johnson

  Cancer induces inflammation and depressive-like behavior in the mouse: Modulation by social housing

  Brain, Behavior, and Immunity. 2011;25(3):555-564.

• 500.

  2011

  Anil K. Sood; Marsha T. Wilson; Thomas J. Herzog

  Supporting gynecologic cancer research: The last 20 years and beyond

  Gynecologic Oncology. 2011;120(3):319-320.